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Abstract 
     Protection from the negative effects of solar radiation can be achieved by wearing 
protective clothing, avoiding exposure to sunlight or by the application of topical 
sunscreens.  In this thesis, a number of studies were designed to determine if quercetin is 
suitable for use as a topical sunscreen.  
     The first objective was to determine if quercetin could protect against UV-induced 
lipid oxidation. Quercetin is twice as effective at preventing UVB-induced oxidation as 
preventing UVA-induced oxidation.The difference between UVA- and UVB- induced 
oxidation is believed to be due to the presence of an excited state form of quercetin in the 
UVA system.   
     The second objective was to determine the UV photostability of quercetin in solution. 
Three photoproducts of quercetin form regardless of whether UVA or UVB radiation is 
used.  These photoproducts are 2,4,6-trihydroxybenzaldehyde, quercetin depside and 
hydroxytyrosol.  .  The slow rate of formation, less than 20% loss of starting material 
over 11 hours, and non-toxic nature of the photoproducts indicate that photostability of 
quercetin is not an obstacle to its use as a sunscreen. 
     The third objective was to determine the ability of quercetin to inhibit 
photosensitization by ketoprofen. Quercetin was shown to be effective in preventing 
decomposition of ketoprofen until it was consumed in the formation of the three quercetin 
photoproducts.  This abilty of quercetin to prevent ketoprofen photosensitization indicates 
a beneficial effect for the use of quercetin as a topical sunscreen. 
     The fourth objective was to determine if quercetin can prevent UV-induced damage in 
a biological system. Quercetin was found to significantly reduce secretion of matrix 
metalloprotease 1 (MMP-1) upon UVA or UVB exposure, but had no effect on secretion 
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of tumor necrosis factor α (TNF-α) in HaCaT cells. , Topical application of quercetin to 
UVA or UVB exposed EpiDerm skin mimics significantly reduced both MMP-1 and 
TNF-α secretion.   
     These results indicate that quercetin is effective in decreasing or eliminating several 
harmful effects of UVA and UVB radiation in the skin without major loss of starting 
material and without formation of toxic photoproducts.  As such, quercetin appears to be 
a good candidate for inclusion into topical sunscreen formulations. 
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1. Abstract 
     Protection from the negative effects of solar radiation can be achieved by wearing 
protective clothing, avoiding exposure to sunlight or by the application of topical 
sunscreens.  In this thesis, a number of studies were designed to determine if quercetin is 
suitable for use as a topical sunscreen.  
     The first objective was to determine if quercetin could protect against UV-induced 
lipid oxidation. Quercetin is twice as effective at preventing UVB-induced oxidation as 
preventing UVA-induced oxidation.The difference between UVA- and UVB- induced 
oxidation is believed to be due to the presence of an excited state form of quercetin in the 
UVA system.   
     The second objective was to determine the UV photostability of quercetin in solution. 
Three photoproducts of quercetin form regardless of whether UVA or UVB radiation is 
used.  These photoproducts are 2,4,6-trihydroxybenzaldehyde, quercetin depside and 
hydroxytyrosol.  .  The slow rate of formation, less than 20% loss of starting material 
over 11 hours, and non-toxic nature of the photoproducts indicate that photostability of 
quercetin is not an obstacle to its use as a sunscreen. 
     The third objective was to determine the ability of quercetin to inhibit 
photosensitization by ketoprofen. Quercetin was shown to be effective in preventing 
decomposition of ketoprofen until it was consumed in the formation of the three 
quercetin photoproducts.  This abilty of quercetin to prevent ketoprofen 
photosensitization indicates a beneficial effect for the use of quercetin as a topical 
sunscreen. 
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     The fourth objective was to determine if quercetin can prevent UV-induced damage in 
a biological system. Quercetin was found to significantly reduce secretion of matrix 
metalloprotease 1 (MMP-1) upon UVA or UVB exposure, but had no effect on secretion 
of tumor necrosis factor α (TNF-α) in HaCaT cells. , Topical application of quercetin to 
UVA or UVB exposed EpiDerm skin mimics significantly reduced both MMP-1 and 
TNF-α secretion.   
     These results indicate that quercetin is effective in decreasing or eliminating several 
harmful effects of UVA and UVB radiation in the skin without major loss of starting 
material and without formation of toxic photoproducts.  As such, quercetin appears to be 
a good candidate for inclusion into topical sunscreen formulations. 
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2. Literature Review 
2.1 Introduction 
     Due to an aging population and a depletion of atmospheric ozone, the average North 
American’s total lifetime exposure to sunlight, both in the visible and ultraviolet 
spectrum, is increasing yearly.   
     Ultraviolet radiation (UVR) produced by the sun and reaching the earth has the ability 
to interact with biological systems in a number of ways (Section 2.2), some of which are 
deleterious to the organism in question.  These negative effects on biological systems 
include initiation of both melanomic (Section 2.3.1.1) and non-melanomic (2.3.1.2) skin 
carcinomas, resulting from effects of UVR in the 280-315 nm (Section 2.3.2) and 315-
400 nm (Section 2.3.3) ranges.  UVR can also cause production of reactive oxygen 
species (ROS) in skin (Section 2.3.4.1) leading to a variety of effects.  The most notable 
of these ROS-dependant UVR effects are decreases in the skin’s anti-oxidant defences 
(Section 2.3.4.2), lipid peroxidation which can lead to necrosis (Section 2.3.4.3), 
induction of a variety of enzyme cascades with various deleterious outcomes (Section 
2.3.4.4), and photoaging effects (Section 2.3.4.5).  Finally, UVR has been shown to cause 
photoimmunosuppression in the skin (Section 2.3.5).    
     Due to the potentially harmful effects of sunlight, especially solar UVR, protection 
from sunlight has become a significant health concern.  The simplest way to prevent 
UVR damage is to simply avoid sunlight by remaining indoors during peak daylight 
hours or wearing protective clothing.  However, for various reasons, these steps may not 
always be a desirable option, which has led to the development of a variety of topical 
skin protectants commonly referred to as sunscreens.  A large number of sunscreens are 
currently commercially available, but these have a number of associated problems such 
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as a lack of wide spectrum protection and issues with photostability (Section 2.4.1).  Due 
to the shortcomings of the currently available commercial sunscreens and the public’s 
interest in natural products, a number of plant extracts have been and are being 
investigated for their potential use as sunscreens (Section 2.4.2).  However, to date none 
of these compounds have been successfully brought to market, making this an active area 
of research. 
     One natural product that has potential for use as a sunscreen ingredient is the flavanol 
quercetin (Section 2.5.1.1).  Quercetin is known to act as an efficient anti-oxidant, though 
the efficiency and capacity are not well characterized, and it is susceptible to oxidation, 
resulting in a number of products (Section 2.5.1.2).  Although the chemical oxidation of 
quercetin is well studied, the photochemistry, beyond the knowledge of strong UVR 
absorption, has been only minimally studied (Section 2.5.1.3).   
     Quercetin is a naturally occurring component of many plant species and as a result is 
found in most diets (Section 2.5.2.1).  Due to its common occurrence in edible plants, the 
absorption (Section 2.5.2.2) and metabolism (Section 2.5.2.3) of quercetin have been well 
documented.  Quercetin has been found to have a number of beneficial effects in animals 
when ingested including anti-oxidant effects (Section 2.5.3.1) and effects on various 
enzyme systems (Section 2.5.3.2).  In addition, quercetin has been found to be 
upregulated in some plants in response to UVR exposure, indicating a role in 
photoprotection.  This photoprotective ability has also been demonstrated in animals fed 
high levels of quercetin (Section 2.5.3.3). 
     Although the need for effective sunscreens and the demand for natural products to 
fulfil this need are well known, the natural polyphenol quercetin which has been shown 
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to have photoprotective properties has mainly been studied as an ingested or injected 
photoprotectant, with limited information available on its properties as a topical 
photoprotectant.  We propose that quercetin will be an effective topical sunscreen due 
protection by UVR screening, free radical scavenging and enzyme modulation. 
     In the studies presented here, quercetin’s ability to prevent ROS induced lipid 
peroxidation, induction of a MMP-1, a protein associated with photoaging, and TNF-α, a 
protein induced by thymine dimer formation and associated with immunosuppression will 
be assessed.  Quercetin’s photostability will also be assessed and the identity of any 
decomposition products will be determined.  In addition the ability of quercetin to 
prevent drug-associated photosensitization will be investigated using the anti-
inflammatory drug ketoprofen as a model system. 
2.2. Ultraviolet Radiation and Photochemistry 
2.2.1 - Electromagnetic Radiation 
     The spectrum of electromagnetic radiation (EMR) ranges from very low energy 
radiowaves to very high energy γ-waves and cosmic rays [1].  Visible light and 
ultraviolet radiation comprise a small part of the broad spectrum of electromagnetic 
radiation (EMR).  An overview of the electromagnetic spectrum is shown in Figure 2.1. 
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Figure 2.1 - The Electromagnetic Spectrum [2] 
     The energy of the electromagnetic spectrum posseses the properties of both waves and 
of particles having no mass, but having momentum [1].  For the purposes of 
photochemical processes, it is best to consider EMR as a wave of particles as this best 
explains the interaction of light with matter [3].   
     EMR is measured using a variety of units such as hertz, wavenumber and wavelength.  
The units used generally vary with the energy of the EMR being considered, with such 
units as are convenient being used.  For the visible and ultraviolet portions of the 
electromagnetic spectrum wavelength (λ), defined as the distance between two 
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consecutive peaks of the EMR, is the most common unit and will be used throughout this 
thesis.   
 2.2.2 - Ultraviolet Radiation 
     Ultraviolet radiation (UVR) is defined as EMR in the range of 100 nm to 400 nm [4] 
This range is commonly subdivided into three sections:  the UVC ranging from 100 nm 
to 280 nm, the UVB ranging from 280 nm to 315 nm and the UVA ranging from 315 to 
400 nm [4].  As the wavelength increases, the energy of the electromagnetic radiation 
decreases so the energy of UVR is UVC > UVB > UVA.   
     Of the UVR that reaches the atmosphere of Earth, 100% of the UVC and 90% to 99% 
of the UVB is absorbed by ozone in the upper atmosphere [5].  As a result the UVR that 
reaches the surface and is of biological significance is between 1% and 10% UVB, 
depending on latitude and elevation, with the remainder being in the UVA range [6].  In 
the United States, the typical total UVR dosage per year ranges from 540000J/m
2
 in 
Bozeman, MT to 970000 J/m
2
 in Riverside, CA [5].  
2.2.3 - Interaction of Electromagnetic Radiation with Molecules 
2.2.3.1 – Chromophores 
     In order for light to interact with matter, including biological systems, the radiation 
must interact with a molecule that is capable of absorbing light in the UV range [1].  The 
portion of a molecule which absorbs EMR is referred to as a chromophore [1] and is 
responsible for the interaction of matter and light.  In the case of UVR chromophores, 
these consist of π electrons in unsaturated systems, or non-bonding pair electrons such as 
found on nitrogen or oxygen [1].   
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     The efficiency with which a molecule or portion thereof absorbs EMR is quantified by 
the molar extinction coefficient or molar absorptivity constant of the absorbing species 
[3].  The molar extinction coefficient (ε) has units of L.cm-1mole-1, and is determined at 
each wavelength of EMR.  Typical ranges of ε for biological molecules in the UV range 
can vary between 10 L
.
cm
-1
mole
-1
 and 30000 L
.
cm
-1
mole
-1, with those molecules having ε 
values in the 20000 L
.
cm
-1
mole
-1
 to 30000 Lcm
-1
mole
-1
 generally considered as strong  
chromophores. 
2.2.3.2 - Excited Species 
     Absorption of EMR by molecules results in a change in energy state of the absorbing 
species to a higher energy level.  In the case of radiation in the UV range, the absorbed 
energy is sufficient for a ground state electron of the absorbing molecule to be raised to a 
higher energy state, considered an excited state [1].  The electron raised to the higher 
energy state maintains its quantum spin number (½ or -½), resulting in the excited 
molecule having paired electrons and initially being in what is termed an excited singlet 
state [1,3].   
     The excited species of molecule is generally unstable and will quickly lose energy in 
order to return to the ground state.  This loss of energy, or deactivation, can occur by a 
number of pathways [1].  The most common pathway of deactivation is internal 
conversion coupled with vibrational relaxations which involves interaction with other 
molecules in the sample, resulting in the loss of energy as heat or through transfer of the 
energy to another molecule.  The transfer of energy to another molecule is termed 
sensitization.  A portion of the excitation energy may also be lost due to a process called 
intersystem crossing, which occurs when the excited electron undergoes a spontaneous 
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spin change, losing energy in the process.  This process results in the formation of a 
triplet state, which although still an excited state is at lower energy then the excited 
singlet state.  The additional energy is then lost through one of the other deactivation 
mechanisms.  The third possible pathway of energy loss is the emission of a photon, 
either from the first singlet or first triplet state resulting in fluorescence or 
phosphorescence, respectively.  The final path by which excitation energy may be lost is 
dissociation in which the excitation energy is high enough to overcome the bond energy 
in one or more of the bonds of the molecule, resulting in bond cleavage.  It is this 
mechanism of deactivation that may also give rise to photochemical reactions [7].  The 
pathways by which an excited state electron may lose energy are summarized in a 
Jablonski diagram in Figure 2.2 
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Figure 2.2 - Sample Jablonski diagram showing possible mechanisms of relaxation 
for an excited state electron.  1 - absorption of a photon, 2 - internal conversion and 
vibrational relaxation, 3 - fluorescence, 4 - sensitization, 5 - inter-system crossing, 6 - 
phosphorescence   
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2.2.4 - Summary 
     Each day the sun produces large amounts of electromagnetic radiation across the 
entire spectrum.  Only a small portion of this radiation reaches the surface of the earth, 
primarily radiation in the ultraviolet, visible and infrared ranges.  Although this is only a 
small portion of the sun’s total output, it is the ultimate source of the majority of energy 
consumed on Earth. 
     In addition to providing the major portion of the Earth’s energy, electromagnetic 
radiation also interacts directly with biological systems through absorption of light.  
Some of the consequences of this interaction between EMR and biological systems will 
be discussed in the next section. 
2.3. Biological Effects of Ultraviolet Radiation 
2.3.1 Skin Cancer 
     Human skin cancers are a major health concern in North America, Europe and 
Australia [8-10].  In the United States alone, over a million new cases of skin cancer are 
diagnosed each year [10,11], accounting for roughly 40% of new cancer cases [9,12,13].  
Skin cancer can generally be divided into two broad categories, malignant melanomas 
which have recently shown a 5% increase each year in North America and Europe [8]  
and non-melanomic skin carcinomas (NMSC), which are the second most common 
cancers in the United Kingdom [14,15]. 
2.3.1.1 Melanoma   
     Melanomas are, as the name indicates the result of mutations in the skin’s 
melanocytes resulting in uncontrolled proliferation and are highly aggressive [15].  
Although melanomas account for only 4% of diagnosed skin cancers, they are more 
likely to metastasise than NMSC’s resulting in a high rate of mortality [10].  In fact, 
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melanomas account for roughly 8000 deaths per year in the United States [9], and are the 
most lethal of skin cancers [15].  Melanomas are associated with both the UVA and UVB 
ranges of solar radiation with UVB causing direct DNA damage and UVA acting through 
the melanin [8,14,15]. Melanomas are most commonly the result of a single, or very few, 
intense exposure events resulting in severe sunburn (edema), often occurring early in life 
[15], and generally present clinically as either a newly formed mole with uneven margins 
or as changes, such as growth, in a pre-existing mole [16].   
2.3.1.2 Non-melanomic  Skin Carcinomas (NMSC) 
      NMSCs account for roughly 96% of the diagnosed cases of skin cancer [15].  These 
skin cancers result from damage to the keratinocytes, the major component cells of 
human skin [15].  NMSCs can be further sub-categorized into squamous cell carcinomas 
(SCC) and basal cell carcinomas (BCC) [12]. 
2.3.1.2.1 Basal Cell Carcinoma (BCC) 
     BCCs are the single most common type of skin cancer [10] accounting for roughly 
80% of the diagnosed skin cancers in North America [12,15] and Australia [10].  BCC is 
associated with lifelong exposure to UVB radiation [12], although intermittent exposure 
during childhood may play a more significant role than exposure later in life [15].  BCC 
does not have a characteristic precursor lesion [15] and is most commonly found on the 
head and face as well as other commonly sun-exposed areas of the body [10].  Although 
several forms of BCC exist, the most common is noduloulcerative BCC which presents 
clinically as a pearl coloured nodule with a central pit and dilated blood vessels around 
the edges [10].  BCCs are generally considered to be the least dangerous form of skin 
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cancer as they do not metastasise [9], but are still a serious problem as they can be locally 
destructive, and if they occur in exposed areas, are quite disfiguring [10]. 
2.3.1.2.2 Squamous Cell Carcinoma (SCC) 
     SSC are the rarer form of NMSCs accounting for 16% to 20% of diagnosed skin 
cancer [10,12].  Like BCC, SSC is caused by DNA damage to the keratinocyte [15], but 
unlike BCC is characterized by mutations in the p53 gene [12].  Also unlike BCC, SCC 
has a characteristic precursor lesion, as most BCC’s form from non-cancerous actinic 
keratoses lesions [15], although SCCs can form de novo [10].  SCC is strongly associated 
with lifelong exposure to UVB which results in the characteristic mutation in exposed 
tissues [15].  However, a smaller number of SCC’s are associated with exposure to the 
lower energy UVA wavelengths [17,18].  These UVA induced SCC’s differ from the 
UVB induced lesions in that they do not involve mutations to the p53 gene [19] and in 
that they occur in the dermis rather than the epidermis due to the greater penetrating 
power of UVA radiation [17].  SCC may present clinically as a thickened scaling patch of 
skin, a persistent skin ulcer, or a cyst-like nodule [10].  Although not as dangerous as 
melanomas, SCC’s are more invasive and destructive than BCC’s and metastasise 
roughly 10% of the time [9].   
 2.3.2 UVB Induced Skin Cancer 
     UVB radiation (280nm-315nm) is the primary wavelength range of light associated 
with the induction of skin cancer [20-23].  The UVB wavelengths are directly absorbed 
by the nucleic acids that make up DNA, mainly by the pyrimidine bases thymine and 
cytosine (and uracil in RNA) [22]  
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     Although the first experiments indicating that UVB could damage DNA used the 
photosensitizer acetophenone [24], it had since been well established that UVB radiation 
can cause direct damage to DNA, with the primary lesions being cyclo-pyrimidine dimers 
(CPDs), especially thymine-thymine CPDs (T<>T) [25-28].  Other lesions which occur 
due to direct UVB absorption by DNA include thymine-cytosine CPDs (T<>C), thymine-
thymine 6-4 photoproducts (T(6-4)T) and thymine-cytosine 6-4 photoproducts (T(6-4)C), 
along with the Dewer isomers of the 6-4 photoproducts [23,27,29] as shown in Figure 
2.3.  The relative frequency of direct UVB lesions in fibroblasts was found to be T<>T > 
T(6-4)C > T<>C > T(6-4)T. [27]   
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Figure 2.3 - UVB Photoproducts 
     CPDs form as a result of [2+2] cycloaddition between the C5-C6 double bonds of 
adjacent pyrimidines [22].  The cis-syn isomer forms more frequently than the trans-syn 
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isomer, while formation of the cis-anti and trans-anti isomers are sterically impossible in 
whole DNA [22].  Computational studies have found that the prevalence of the T<>T 
lesion is due to the fact that this lesion has the lowest excited state energy barrier 
compared to the other possible lesions, resulting in its favoured formation [21]. 
     In many species, including bacteria, plants and some animals, UVB induced damage is 
repaired by the UVA activated DNA repair enzyme photolyase [26,30].  However, this 
enzyme is lacking in humans, necessitating other repair mechanisms [30].    
     In humans and other mammals, repair of UVR induced CPDs as well as DNA adducts 
and cross-links are repaired primarily by the nucleotide excision repair (NER) system 
[11,31].  The proteins responsible for the NER system are the products of at least twenty 
genes which together carry out five steps required for DNA repair [11,32].  The first step 
in NER is recognition of DNA damage due to distortions of the DNA double helix.  Once 
the damaged site is recognized, the two DNA strands are separated by two DNA 
helicases [11].  A 24 to 30 nucleotide long section of the damaged strand containing the 
damaged bases is then excised.  This excision occurs first at the 3' end of the damaged 
section followed by the 5' end and has an efficiency of 30-40% in 5 to 7 hours [32].  
Once excised the damaged section of DNA is removed and the gap is filled by a DNA 
sythase using the non-damaged strand as a template.  The excision strands are then closed 
by a DNA ligase, and the repair is complete [11].  This repair system is highly conserved 
in animals, but interindividual variation in efficiencies of up to 20x exist [33].        
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2.3.3 UVA Induced Skin Cancer  
2.3.3.1 Oxidative Lesions 
     Although it is mainly UVB radiation that is associated with induction of skin cancer, it 
has been shown that UVA can play a significant role in carcinogenesis as well [8,19,34-
36].  Although UVA has a lower energy than the UVB range of solar radiation, UVA 
accounts for roughly 90% of the UV radiation that reaches the earth’s surface, resulting 
in similar impact of the two ranges of UVR on skin [5,10]. 
     Although the thymine (and to a lesser extent cytosine) residues in DNA provide a 
good UVB chromophore, and can directly absorb UVB energy [37], the absorption by 
thymine and other components of DNA in the UVA range is quite weak [37].  As a result, 
most of the UVA effects on DNA are mediated through ROS, via either type I or type II 
photoreactions, with oxidized purines outnumbering CPD’s by 3 to 1 following UVA 
exposure [38]   
     The skin contains a number of compounds capable of absorbing UVA radiation and 
transferring the energy to molecular oxygen in order to form ROS [39].  Wondrak, et. al. 
have shown that protein bound advanced glycation end-products (AGE’s) can be excited 
by UVA to cause O2 dependant and independent DNA cleavage [40].  The same group 
also showed that unmodified collagen and elastin in the skin as well B6 vitamirs can act 
as UVA sensitizers to ROS mediated DNA damage [41,42].  Pouget, et al. have shown 
that the major ROS associated with UVA exposure is 
1
O2 rather than H2O2 [22,43] 
     As stated earlier, the main DNA lesions caused by UVA exposure are formed via 
ROS, with the most common lesion being 8-hydroxyguanine (8-oxoG) [22,28,44,45]   
The result of this alteration to the guanine base is most commonly a deletion mutation in 
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the complementary strand directly across from the oxidized guanine [46], although G to T 
transversions may also occur [19]. 
2.3.3.2 UVA Photoleisons    
     In addition to oxidative lesions, UVA radiation is also associated with thymine dimer 
formation [17,36,38,47].  UVA is a much weaker inducer of thymine dimers than UVB, 
about three orders of magnitude less efficient [35,38], the abundance of UVA results in 
number of CPD’s resulting from the UVA portion of sunlight [17].   
     Although UVA is much lower in energy than UVB, the greater abundance of UVA 
and its ability to induce oxidative damage means that UVA poses a significant skin 
cancer risk at environmental levels [8,17,36].  An interesting aspect of this UVA 
damaged DNA is the stratification of damage.  Due to the greater penetrating power of 
UVA compared to UVB radiation, DNA damage caused by UVB tends to be found in the 
upper layers of the skin while UVA damage in occurs basally located cells [17].  
 
Figure 2.4 - Cross-sectional diagram of human skin showing the three main layers of  
the skin and the component cells [48] 
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2.3.4 Oxidative Stress 
2.3.4.1 Reactive Oxygen Species Generation 
     In addition to damage to DNA by direct absorption, UVR may cause other deleterious 
effects in the skin.  The most significant of these damages is the generation of reactive 
oxygen species in the skin by both UVA [49] and UVB [50] radiation.   UVR has been 
shown to generate a number of different ROS in the skin including the primary species 
singlet oxygen (
1
O2) [49,51-54] and superoxide radical (O2
.-
) [55-57] and the secondary 
species hydrogen peroxide (H2O2) [41,49,56,58] and hydroxyl radical (
.
OH) [50,56].   
     The primary ROS are produced through either a type I photoreaction wherein energy 
is transferred from an excited state chromophore to a target molecule which then reacts 
with molecular oxygen (
3
O2) to generate the ROS or a type II photoreaction where the 
excited state chromophore transfers energy directly to molecular oxygen to generate the 
ROS.  Predictably, the type II photoreaction is more efficient [59].  Singlet oxygen and 
superoxide are subsequently converted to H2O2 either by superoxide dismutase (SOD) 
[60] or spontaneously at neutral pH’s [61] in the case of O2
.-
 or anti-oxidants such as 
ascorbate in the case of 
1
O2 [62].  H2O2 is less reactive than either 
1
O2 or O2
.-
, and freely 
diffuses across membranes, potentially reaching all parts of the cell [63].  H2O2 can then 
be reduced to the highly reactive hydroxyl radical by Fe(II) or Cu(II) present in the cell 
via a Fenton reaction [61].   
     In order to generate ROS, UVR must first be absorbed by a molecule in the skin, 
referred to as a chromophore.  A variety of different molecules have been identified as 
serving as UV chromophores in human skin.  One of the most important UVR 
chromophores in the skin is DNA [37].   However, UV absorption by DNA is generally 
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associated with DNA lesions rather than the generation of ROS as discussed in sections 
2.3.2 and 2.3.3.1.   
     Another well studied UVR chromophore in skin is urocanic acid (UCA) which is 
found in high levels in the stratum corneum, the upper most layer of the epidermis.  
Urocanic acid (Figure 2.5) is produced by the deamination of histidine by histidine 
ammonia lyase [14].  Urocanic acid exists normally in the skin as the trans isomer, but 
exposure of trans-UCA to UVR results in a photoisomerization to cis-UCA [14,64].  In 
addition to the photoisomerization, the absorption of UVR, specifically UVA, by UCA 
results in the formation of 
1
O2 [64].   The UCA then reacts with the 
1
O2 formed to form 
oxidation products which include species that also absorb UVR increasing the rate of 
1
O2 
and peroxide formation [64].   
N
N
OH
O
H
 
Figure 2.5 - Urocanic acid 
    Other endogenous small molecules in the skin may also act as photosensitizers.  These 
include bilirubin [65], B vitamers [42] and tryptophan [66] which are all water soluble 
and contain UVR absorbing π electrons as well as ionizable oxygens which leads to the  
generation of H2O2 when exposed to UVR in the presence of oxygen.  Also implicated as 
photosensitizers are pterins which produce 
1
O2 in response to UVA [67] and flavins such 
as riboflavin which produces both 
1
O2 and O2
.-
 when exposed to UVR [68].  Finally a 
variety of porphyrins may also act as photosensitizers [69]. 
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     In addition to small molecules and DNA, proteins - both modified and unmodified - 
can act as UVR chromophores for the generation of ROS.  Wondrak, et. al. have shown 
that simulated solar radiation (SSR) and UVA alone can be absorbed by extracellular 
matrix (ECM) proteins in the skin such as collagen and elastin, resulting in the 
production of H2O2 which can then enter the cell across the plasma membrane [41].  The 
photoreductive formation of H2O2 by UVA and SSR also results in the oxidation and 
subsequent fragmentation of the ECM proteins [41].  This same group later showed that 
the portion of the ECM proteins primarily responsible for the UVR absorption and ROS 
generation are the hydroxypyridine containing cross-links [42].  It was further 
demonstrated that the minimum hydroxypyridine derivative sensitizer chromophores are 
3-hydroxypyridine for UVB and N-alkyl-3-hydroxypyridinium in the case of UVA [42].  
In addition to the ECM proteins elastin and collagen, UVB exposure absorption by 
catalase can also result in the formation of ROS.  Although catalase is normally 
associated with the reduction of H2O2 to H2O, Heck, et. al. have shown that in 
keratinocyte cultures exposed to UVB, catalase caused the formation of superoxide and 
subsequently H2O2 [70].  
     Although unmodified ECM proteins can act as UVR sensitizers, modified proteins are 
generally more effective in this role.  AGE’s are formed by spontaneous protein damage 
caused by reactive carbonyl species such as reducing sugars [71].  These protein 
modifications, many of which have a UVA chromophore consisting of pi electrons, 
accumulate on long lived proteins such as the skin proteins collagen and elastin during 
normal skin aging [72].  When exposed to UVA, these protein modifications have been 
shown to generate a variety of ROS including H2O2 [39], O2
.-
  and 
.
OH [56] in both 
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keratinocytes [39] and fibroblasts [56].  In addition to generating ROS, AGEs have also 
been shown to cause cleavage of DNA directly upon absorption of UVR in a Type I 
photoreaction in cell culture systems [40]. 
2.3.4.2 Antioxidant status of photoexposed skin 
     Normal healthy skin serves as the body’s first line of defence against a variety of 
environmental insults and as a result has a number of natural defences, particularly 
against oxidative stress.  These defences include enzymatic defences such as SOD, 
catalase, glutathione peroxidase and glutathione reductase as well non-enzymatic 
defences such as ascorbate, glutathione (GSH), α-tocopherol and ubiquinol [63,73,74]. 
     Predictably, the increase in ROS in the skin caused by exposure to UVR can result in a 
strain on this antioxidant defensive system.  Using mice exposed to 25 J/cm
2
 of simulated 
solar light, equivalent to 5 hours of autumn sunlight at 38° N, Yasuko, et. al. showed that 
glutathione peroxidase and glutathione reductase both showed slight but significant 
decreases in both the dermis and epidermis following exposure while catalase and SOD 
showed large decreases in protein levels and activity [75].  In the same study, ubiquinol 
was found to completely disappear following exposure while α-tocopherol decreased by 
30%, ascorbate decreased 53% in the epidermis and 68% in the dermis and GSH 
decreased, but not significantly, in both dermis and epidermis [75].  The same group later 
demonstrated similar results using much lower doses of 2 to 12.5 J/cm
2
 [73].  These 
results are supported by the findings of other groups such as Aldini et. al. who showed 
that UVB exposure decreased GSH levels in human skin cell cultures [76]. 
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2.3.4.3 Lipid Peroxidation 
     Following depletion of the skins anti-oxidant defences, continued UVR induced 
production of ROS leads to a build up of these reactive molecules which can cause a 
number of types of damage in the skin, such as lipid peroxidation.  Lipid peroxidation 
occurs when a hydrogen atom is abstracted from a methylene carbon in the side chain of 
a lipid, which is made easier by increasing degrees of unsaturation, by a hydroxyl radical  
[77].  This abstraction produces a carbon-centred radical which quickly reacts with 
ground state molecular oxygen to form a peroxyl radical [55,77,78].  This process can 
then repeat via one-electron reduction of an adjacent lipid resulting in a self propagating 
chain reaction (scheme 2.1) [78].  Alternatively, interactions with an anti-oxidant species 
can result in a two-electron reduction, terminating the chain [78,79].   
 
LH + R· → L∙ + RH 
L∙ + O2 → LOO
∙ 
 
 
 
 
LOO· + AOH ——→ LOOH + AO-                   LOO· + LH ——→ LOOH + L· 
(Termination)                                                     (Propagation) 
 
Scheme 2.1 
 
     The formation of the lipid peroxide may also be initiated by singlet oxygen, giving 
rise to the reduced species [78] as shown in scheme 2.2. 
 
LH + 
1
O2 ——→ LOOH 
 
Scheme 2.2 
 
1e 2e 
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     It should also be noted that the propagation of the peroxidation seen in scheme 2.1 is 
not confined to adjacent lipids as the lipid radical species may move within or between 
membranes [78]. 
     Exposure to UVR has been shown to be linked to lipid peroxidation in a number of 
systems including epidermis homogenate [50,55] and HeLa cells [80,81].  Electron spin 
resonance (ESR) studies showing the co-occurrence of UVR induced ROS and lipid 
peroxidation [50,55] as well as a linear relationship between the dose of UVR, ROS 
formation and lipid peroxidation [50] indicate a causative role for ROS in UVR induced 
lipid peroxidation. 
     The overall effect of these ROS induced lipid peroxides is to alter the structure and 
function of the membranes in which they occur as they generally have a greater polarity 
then the parent lipids [78].  One of the alterations seen in oxidized lipid membranes is an 
increase in rigidity or loss of fluidity.  This loss of fluidity can cause a decrease in cell 
function as membrane bound proteins can no longer move freely or cell death as the 
membrane becomes leaky [49,55,82].  
     UVR induced lipid peroxides have also been implicated in a number of secondary 
effects.  One of the products of membrane lipid peroxidation is 4-hydroxynonenal (4-
HNE) [83].  4-HNE has been shown in cultured cells to increase in a dose dependant 
manner with UVA irradiation, and that the increased levels of 4-HNE, which forms DNA 
and protein adducts, leads to an increased rate of apoptosis [83].  In addition changes in 
the fluidity of cellular membranes have been suggested to have an effect on cell surface 
receptor proteins.  Rosette et. al. found that UVB radiation caused multimerization, 
clustering and internalization of the cell surface receptors for epithelial growth factor 
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(EGF), tumour necrosis factor (TNF) and IL-1 identical to that seen when the receptors 
bind to their appropriate ligand, which initiated a series of enzyme cascades within the 
cells (see section 3.4.4)[80].  These findings are supported by later work which found that 
UVB radiation can cause the release of IL-6 [84] and activation of the CD95 death 
receptor [81] in a membrane mediated, DNA independent manner.  Although the 
mechanism is not clear, it has been suggested that changes in membrane fluidity caused 
by lipid peroxidation are the cause of these clustering effects [80,85].       
2.3.4.4 UVR Induced Enzyme Cascades  
    Although the process leading from the generation of ROS to the activation of various 
cell surface receptors is not entirely clear [80,85], it is well established that UVA and 
UVB radiation can initiate a number of enzyme cascades inside the cell [34,51,60,86-88].   
     UVR exposure of keratinocytes and fibroblasts has been shown to cause the 
production and release of a number of cytokines.  Fibroblasts exposed to UVR have been 
shown to release IL-1α and IL-1β which then initiate the de novo synthesis of more IL-1α 
and IL-1β creating a positive feedback loop [89].  IL-1α and IL-1β release has also been 
demonstrated in stratified epithelium containing both fibroblasts and keratinocytes.  This 
release was correlated to cytotoxicity, and interestingly was not affected by thickness of 
the skin, likely due to the penetrating power of UVA and UVB radiation.  This 
penetrating power is due to the short wavelength of UVR being such that interference 
with many skin components does not occur [90].   
     The UVR induced activation and production of IL-1 has a number of downstream 
consequences.  IL-1 can cause the release and production of IL-6 [89] which has been 
shown to be increased in UVA exposed fibroblasts [89,91,92], keratinocytes [90], HeLa 
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cells [84], stratified epithelium [90], and in humans in vivo [93], usually in association 
with IL-1α and IL-1β.   
     UVR induced activation of the cytokine receptors, either through induction of 
interleukin release and production [89,90,92,94] or through membrane effect activation 
[80,85], has also been shown to result in the initiation of a kinase cascade leading to 
activation of AP-1 [88,95,96].  Activation of cytokine receptors first causes the 
recruitment of the small GTP-binding proteins Ras [97], and Rac [98].  These proteins in 
turn activate mitogen activated protein kinase kinase kinase 1 (MAPKKK1 or MEKK1) 
[99].  In addition to acting thorough membrane effects, intracellular ROS, specifically 
.
OH may also activate MEKK1 directly [60].   
     Activated (phosphorylated) MEKK1 in turn phosphorylates mitogen activated protein 
kinase kinase 4 (MAPKK4 or MEK4) with then phosphorylates MEK7 [60].  MEK7 acts 
on the c-Jun N-terminal kinase (JNK) protein, activating it through phosphorylation of 
residues Thr183 and Tyr185, as well as activating the p38 protein by phosphorylation of 
Thr180 and Tyr182 [86,100].  The activation of JNK and p38 has been shown to occur in 
fibroblasts [52,53], HaCaT (keratinocyte) cells [101] and photoaged skin [95]. 
     JNK, and to a lesser extent p38, act on the c-Jun protein, phosphorylating it at residues 
Ser63 and Ser73, which stabilizes c-Jun and increases its transcriptional activity [88,101].  
The c-Jun protein is a component of activating protein-1 (AP-1) which is composed of a 
homodimer of c-Jun or a heterodimer of c-Jun and one of v-Jun, JunB, JunD, v-Fos, c-
Fos, FosB, Fra1, Fra2, ATF2, ATF3, B-ATF or bZIP [101].  In addition to the activation 
of c-Jun, UVR has been shown to induce the expression of the AP-1 components c-Jun, 
c-Fos, Fra1and Fra2 [96].  The transcriptional activation of AP-1 by JNK mediated 
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phosphorylation of c-Jun along with the increased expression of AP-1 components results 
in the up-regulation of AP-1 controlled genes, among which is the c-Jun gene, resulting 
in a further increase in c-Jun levels [88,95,96,101,102]. 
     AP-1 is involved in a number of cellular functions.  The c-Jun component of AP-1 
appears to be required for growth and development of some cells, especially fibroblasts 
[102].    However, AP-1 has also been implicated in the initiation of apoptosis, 
particularly those types of apoptosis requiring de novo protein synthesis [102], 
particularly through the activity of cytochrome-c [103].  The action of UVR induced AP-
1 may partially explain the induction of apoptosis associated with UVR [103-105] as well 
as the findings that UVR induced JNK can prevent apoptosis [106]. 
     AP-1 also acts to activate matrix metalloprotease (MMP) genes, leading to the 
increase in synthesis and release of MMP-1 and other metalloproteases seen in UVR 
exposed cells [87,89,90,92,95,107-110].  The UVR induced photoaging effects of AP-1 
mediated MMP induction will be discussed in more detail in section 3.4.5.  However, it 
should be noted that UVR can also affect collagen status through regulation of Smad7 
activity.  AP-1 binds to the promoter of the Smad7 gene resulting in an increase in Smad7 
transcription, which results in increased translation and activity.  This increase in Smad7 
results in a decrease in phosphorylation of Smad2 and Smad3 which prevents the 
synthesis of procollagen-I through modulation of the TGF-β pathway [60,111].  
Procollagen –I is converted to collagen-I, so the decrease in procollagen-I, leads to a 
decrease in collagen-I also contributing to the photoaging process [60].  AP-1 is involved 
in the regulation in a number of genes besides those described which have been discussed 
in a number of reviews [102,112].  
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     Exposure of keratinocytes to UVR has also been shown to increase expression of 
intercellular adhesion molecule 1 (ICAM-1) through the generation of ROS [113-115].  
ICAM-1 which is involved in the skin’s inflammatory response as well as tumour 
promotion [113,116], has been shown to be at least partially under the control of 
activating protein-2 (AP-2) which is upregulated by UVR [114].  AP-2 has been shown to 
be activated by IL-1α, which as discussed earlier is induced by UVR [115].  In addition, 
AP-2 may be activated by ceramide which has been shown to be produced from 
sphingomyelin in a non-enzymatic mechanism involving UVR derived ROS, this reaction 
presumably occurring at the cell membrane [117]. 
     The preceding UVR induced enzyme cascade description covers the portion of the 
possible enzyme effects relevant to this project.  A more complete description is available 
in several review articles [34,51,60,86-88].  A graphical presentation of this partial 
enzyme cascade is shown in figure 2.6.        
2.3.4.5 Photoaging 
     In addition to genetic and oxidative damage, ultraviolet light exposure has also been 
associated with acceleration of the aging process, referred to as photoaging [15].   
Photoaging is characterized by increased wrinkle formation relative to unexposed skin, a 
loss of skin recoil capacity and an increase in skin fragility [87,91,118].   Histologically, 
the most prominent feature of photoaged skin is solar elastosis, characterized by 
degradation of collagen and accumulation of abnormal elastin [118,119].   
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Figure 2.6 - UVR induced enzyme cascades 
      
     Collagen is an extracellularly excreted protein that is primarily responsible for 
providing structural integrity to the skin [108], and loss of this protein is the main cause 
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of the skin changes seen in photoaging, although changes to other extracellular proteins 
such as elastin and glycosaminoglycans are also involved [87]. 
     Breakdown of collagen is primarily mediated through the enzyme MMP-1, also 
known as collagenase, which is responsible for the breakdown of interstitial collagen 
[108].  It is the modulation of MMP-1 levels by UVA and UVB radiation that is believed 
to be the main cause of photoaging [87,95,107-110]. 
     The induction of MMP-1 in the skin by ultraviolet radiation has been demonstrated by 
a number of groups.  Using cultured fibroblasts grown from biopsies of healthy donors, 
Herrmann et. al. showed that UVA radiation at a dose of 180kJ/m
2
 could induce MMP-1 
mRNA and de novo MMP-1 protein synthesis and excretion as well as MMP-3 mRNA 
and MMP-2 and MMP-3 protein synthesis and excretion up to 48 hours after exposure 
[120].  This same group had earlier shown that a dose of 10 J/cm
2
 could induce MMP-1 
mRNA in cultured fibroblasts [110].  These findings are supported by the work of 
Vielhaver, et. al. which showed that sunscreens which absorb UVA protect against UV 
induced expression of MMP-1 [92].    
     Working with human skin in vivo, Fisher et al have shown that UVB doses as low as 
10% of the minimal erythema dose (MED) for an individual induce MMP-1 mRNA and 
protein as well as MMP-9 (gelatinase) mRNA and protein up to 48 hours after exposure 
in a dose dependant manner [107].  This same group later showed that MMP-1 mRNA 
was upregulated by UVB in both the dermis and epidermis and that this MMP induction 
led to degradation of skin collagen [109].  This was supported by Onoue, et. al. who 
showed that keratinocytes exposed to UVB, but not UVA, showed an increase in MMP-9 
excretion [121]. 
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     Photoaged skin is distinct from naturally, or chronologically, aged skin in both 
appearance and in biochemical properties.  Superficially, naturally aged skin is smooth, 
pale and finely wrinkled as compared to coarsely wrinkled photo-aged skin [122].  
Biochemically, levels of the matrix-metalloproteases MMP-1, MMP-2 and MMP-9 are 
all elevated in photoaged skin as compared to naturally aged skin [95,122].  In addition, 
photoaged skin has a lower expression of the antioxidant enzymes copper-zinc 
superoxide dismutase (CuZnSOD), manganese superoxide dismutase (MnSOD) and 
catalase (CAT) than naturally aged skin.  This results in an increase in oxidative protein 
damage, specifically the formation of protein carbonyls [119].  Finally, photoaged skin 
shows changes from naturally aged skin in the collagen balance.  In photoaged skin the 
level of procollagen mRNA and protein expression is increased relative to naturally aged 
skin, but due to increases in the MMPs, the total amount of functional collagen is 
decreased in photoaged skin [122]. 
     The balance between synthesis and degradation of collagen is the key factor in 
determining the extent of photoaging in otherwise healthy, young skin.  Comparing sun-
protected and sun-exposed skin from healthy young volunteers, Varani et.al. showed that 
collagen fragmentation was increased in sun-exposed skin [123].  However, in contrast to 
the comparison between naturally aged and photo-aged skin, photo-damaged skin showed 
a reduction in pro-collagen synthesis relative to undamaged skin [123].  Varani further 
found that the inhibition of collagen synthesis was caused, at least in part, by fragmented, 
or degraded, collagen.  This was demonstrated by the fact that fibroblasts removed from 
an area of sun-damaged skin produced collagen normally when the exposure to collagen 
fragments ceased [123]. 
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     Although the complete molecular pathway leading from exposure to UVR to induction 
of the matrix-metalloproteases and photoaging is not entirely clear, some research exists 
concerning the chain of events.  It is well known that both UVA and UVB radiation can 
induce the formation of reactive oxygen species (ROS) in the skin [49,50] and there is 
good evidence that it is these ROS that initiate the photoaging process.  First, the level of 
H2O2, an inducer of MMP-1 [124], has been found to be elevated in photoaged skin 
relative to naturally aged skin, perhaps accounting for the differences in MMP activities 
[95].  Secondly, it has been shown that dark reaction produced 
1
O2, which can be 
converted to form H2O2, induces MMP-1 mRNA in the same dose dependant manner as 
UVA in cultured fibroblasts [124].  In addition, exposure of fibroblasts to UVA resulting 
in MMP-1 upregulation has been shown to be enhanced by the addition of D2O, which 
increases the lifetime of 
1
O2 [125], and that addition of sodium azide, a quencher of 
1
O2, 
dramatically decreases the expression of MMP-1, implicating 
1
O2 in the process [126].  
Taken together, these facts may show that the formation of reactive oxygen species is the 
first step in photoaging.   
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     The enzymatic pathway connecting ROS to photoaging has been filled in by a number 
of groups and appears to involve several interleukins.  It has been determined by 
Wlaschek, et. al. that fibroblasts exposed to UVA show an upregulation in IL-6 mRNA 
and protein and that inhibition of the translation of IL-6 prevents MMP-1 upregulation, 
showing that IL-6 is necessary for increases in MMP-1 activity [91].  This same group 
later showed that following UVA exposure, there is an initial increase in the release of 
existing IL-1 which triggers the de novo synthesis of both IL-6 which leads to MMP-1 
induction and IL-1 which perpetuates the UV response [89].        
2.3.5 Photoimmunosuppression 
     In addition to the effects on DNA, lipid membranes and signal cascades, UVB has 
also been shown to cause immune suppression [15,113].  It is believed that this 
photoimmunosuppression serves to prevent harmful excessive inflammation of the skin 
following exposure to UVR [15].  Although this suppression of the immune system 
occurs first in the skin as expected, it can become systemic [15].  In addition to acute 
occurrence of immunosuppression, long term exposure to doses of UVB too low to 
induce acute immunosuppression have been shown to cause chronic, cumulative 
suppression of the immune system in mice [127]. 
     The initial skin chromophore involved in immunosuppression has been shown to be 
DNA, specifically the formation of cyclobutane dimers.  Yarosh, et. al. demonstrated that 
in HaCaT cells UVB radiation induces the immunosuppressive cytokine TNF-α, and that 
this same cytokine was induced when DNA was damaged using HindIII.  Further, they 
also showed that increased repair of CPDs by addition of T4 endonuclease V, which is 
specific for UVR induced DNA damage, resulted in a decrease in immunosuppression 
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[128].   Similar results have shown that in in vivo human experiments, T4 endonuclease 
V given after SSR exposure prevented immunosuppression [129]. 
     Immunosuppression by UVB occurs via suppression of T-cell mediated immunity 
[15,130] and is controlled through the induction of immunomodulating cytokines.  UVB 
has been shown to induce the production and release of IL-10 in human keratinocytes 
[131] and mice [132-134] the blocking of which results in a loss of immunosuppression 
[131-134].  In addition to IL-10, UVB has also been shown to induce production of IL-4 
[132], IL-6 [133] and TNF-α [132] in mice. 
     The various interleukins induced by UVB radiation appear to have different functions 
in the immunosuppressive effect.  When IL-6 knockout mice are exposed to UVB, the 
loss of contact hypersensitivity seen in wild type mice as well as the increase in IL-6 and 
IL-10 levels in the blood were absent [133].  However, when the knockout mice were 
injected with IL-6, the IL-10 levels increased and immunosuppression was observed, 
indicating that UVB causes induction of IL-6 which in turn induces IL-10 which results 
in immunosuppression [133].  This same study indicated that the cells responsible for IL-
6 production appeared to be Langerhan’s cells [133].  It has also been demonstrated that 
different UVB induced interleukins modulate different types of immunosuppression.  
Rivas et. al. showed that injecting UVB exposed mice with anti-IL-10 reduced the effects 
of UVB on delayed type hypersensitivity but not contact hypersensitivity while anti-
TNF-α decreased suppression of contact hypersensitivity but had no effect on delayed 
type hypersensitivity [132].     
     UVB radiation is associated with both acute and chronic immunosuppression, but 
longer wavelength UVA radiation appears to have the opposite effect.  Reeve, et. al. 
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found that mice exposed to pure UVA radiation immediately after or up to 24 hours 
before exposure to UVB did not show immunosuppression as seen in mice exposed to 
UVB alone, but did not provide a mechanistic explanation [135].  This same group later 
showed that in albino hairless mice UVA radiation induced IFN-γ expression peaked at 1 
day post-exposure followed by IL-12 expression peaking at 3 days post-exposure while 
UVB induced IL-10 expression peaked on day 3.  Exposure to both UVA and UVB 
resulted in a lack of IL-10 expression and decreased IL-12 and IFN-γ expression.  Since 
IL-12 is a known agonist of IL-10, the authors concluded that UVA protects from UVB 
induced immunosuppression by increasing expression of IL-12, likely through IFN-γ 
expression, which decreases IL-10 expression [134].  Reeve, et.al. then showed that the 
UVA induced expression of IFN-γ and IL-12 was mediated through the induction of the 
stress enzyme heme oxygenase-1 [136]. 
2.3.6 Summary 
     Exposure to UVR can cause a number of negative biological effects in humans, 
primarily skin cancer, oxidative stress and immunosuppression.  UVR induced skin 
cancers include the rare but highly malignant melanoma as well as the less malignant but 
more common non-melanomic skin carcinomas basal cell carcinoma and squamous cell 
carcinoma. 
     Skin carcinomas can be induced by both UVB and UVA ranges of solar radiation.  
UVB radiation can be directly absorbed by DNA which may result in the formation of 
CPD’s, particularly thymine-thymine dimers which can cause replication or transcription 
errors if not repaired.  Although UVA radiation can cause direct formation of thymine 
dimers in the same manner as UVB, UVA induced skin caner is more often caused by 
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oxidative DNA lesions.  In these cases, UVA radiation absorbed by endogenous or 
exogenous chromophores in the skin provides the energy for the formation of reactive 
oxygen species with react with DNA, usually at guanine residues to form lesions.  These 
lesions can then cause replication or transcription errors resulting in uncontrolled cell 
growth. 
     In addition to causing oxidative DNA lesions, UVR derived ROS have a number of 
other negative effects.  Due to the harmful effects of ROS, the skin has a number of 
natural defences to eliminate them, however depletion of these defences by UVR 
generated ROS can leave the body more vulnerable to ROS from other sources.  In 
addition, UVR generated ROS can initiate lipid peroxidation which may result in loss of 
membrane function or necrosis.  ROS can also initiate a number of enzyme cascades 
resulting in inflammation, changes in cell growth and development and apoptosis.  
Finally, enzyme cascades initiated by UVR induced ROS can cause photoaging effects by 
causing destruction of interstitial collagen. 
     Finally, UVR has been shown to cause photoimmunosuppression in human skin.  This 
phenomenon is caused by the absorption of UVR (primarily UVB) by DNA resulting in 
the production of IL-10, IL-4, IL-6 and TNF-α.  The induction of these cytokines results 
in both acute and chronic immunosuppression, both locally and systemically. 
     It is clear that while necessary for a number of biological functions, solar UVR also 
has a number of harmful biological effects.  In order to reduce these effects and the 
negative outcomes associated with them it is necessary to reduce the amount of UVR 
exposure most people receive.  One approach to this is the effective use of sunscreens, as 
described in the next section.      
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2.4. Sunscreens 
2.4.1 Commercial Sunscreens 
     With the wide variety of deleterious health effects seen with overexposure to 
ultraviolet radiation (see section 2), a variety of methods to prevent this damage are 
available.  The simplest means of avoiding UVR exposure is avoidance, by staying inside 
during peak sunlight hours or wearing protective clothing [6,137,138].  Since these two 
methods are not always an option, various topically applied photoprotectants, sunscreens, 
have been and are being developed. 
     Early sunscreens were designed to screen only UVB radiation, since the objective was 
to prevent edema and skin cancer, both of which effects are primarily caused by UVB 
[15,25-28].  Organic UVB protecting sunscreens typically consist of an aromatic core 
with two functional groups, one of which readily donates an electron and the other which 
readily accepts electrons, which allow for the dissipation of absorbed UVB energy 
through delocalization of charge across the molecule [6].  The most commonly used UVB 
protecting sunscreens belong to four broad categories of chemicals which are derivatives 
of p-aminobenzoic acids (PABA),  octocrylene, salicylates and cinnamates as shown in 
figure 2.7 [6].   
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Figure 2.7 – UVB Absorbing Sunscreens 
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     The PABAs are exemplified by such compounds as ethylhexyl dimethyl PABA and 
ethyl dihydroxypropyl PABA and the salicylates by such compounds as ethylhexyl 
salicylate and ethyl triazone [6,139].  Cinnamate derivatives include ethylhexyl 
methoxycinnamate and octylmethoxycinnamate, while octocrylene is often used 
unmodified [6,139,140].  These early sunscreens presented a number of problems.  
PABA, one of the first sunscreens introduced in the 1920's, proved to induce 
photocontact allergies and was implicated in causing autoimmune diseases [6].   
     As mentioned, these sunscreens were designed primarily to protect against the effects 
of UVB radiation.  The ability of the compounds to protect against UVB damage is rated 
by the sun protection factor (SPF) which is an indication of how many times longer it 
takes to produce edema compared to unprotected skin.  For example, if under given light 
conditions, sunburn is produced in 1 min, wearing an SPF 15 sunscreen would result in a 
delay of 15 min before sunburn would occur [138].  However, as it became clear that that 
the UVA portion of sunlight could cause health effects such as photoaging [15] and could 
contribute to skin cancer [8,34], the need for broader spectrum sunscreens that protected 
from both UVA and UVB became clear [6]. 
     The first of the new broad spectrum sunscreens, oxybenzone (benzophenone-3) (Fig 
2.8), appeared in the 1980's [6].  However, oxybenzone has been shown to be absorbed 
by the skin and may have estrogenic activities [6].  Since then a new generation of broad 
spectrum sunscreens have been introduced.  These include butyl 
methoxydibenzoylmethane (avobenzone, Parsol 1789), drometrizole trisiloxane (Mexoryl 
XL), and terephthalidene dicamphor sulfonic acid (Mexoryl SX), as shown in Figure 2.8 
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[137-139].  Currently, no universal rating system such as SPF exists for UVA protection 
though such a system has been proposed [138].     
O
O O
Avobenzone
OOH
O
Oxybenzone
N
N
N
Si
O
O
Si
SiOH
Mexoryl LX Mexoryl SX
S
OH
O
O
O
S
HO
O
O
O
 
Figure 2.8 – Broad Spectrum Sunscreens 
     The efficacy of the various sunscreens currently on the market against skin cancer and 
photoaging is not entirely clear.  Using human subjects and solar simulated radiation 
(SSR) over 4 days, sunscreens containing only methoxycinnamate have proven effective 
in the prevention of thymine dimer formation, though other DNA damage was not 
assessed [13].  Similar positive results were seen in human subjects in a long term study 
over two years.  In this case use of a sunscreen containing a mixture of oxybenzone, octyl 
methoxycinnamate and octyl salicylate proved effective in slowing the rate of 
accumulation of actinic keratoses (AKs), a pre-cancerous lesion [141].  Another 
combination sunscreen containing 2-ethylhexyl p-methoxycimmamate, oxybenzone and 
octyl salicylate with an SPF rating of 17 was shown to decrease AKs in humans [142].  
Mexoryl SX has also proven to be an effective sunscreen.  In a study using mice treated 
topically with Mexoryl SX and exposure to SSR resulted in a longer tumour latency 
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period and was determined to have a tumour protection factor of 2.4, compared to 1.3 for 
cinnamates [143].  Mexoryl SX has also been shown to decrease DNA fragmentation in 
cultured keratinocytes as measured by the Comet assay, as well as preventing the 
accumulation of p53, a marker of DNA damage [137]. 
     Although sunscreens appear to be effective against skin cancer, the controversy arises 
over the stability of these compounds when exposed to UVR.  Testing of a sunscreen 
containing octyl methoxycinnamate, oxybenzone and Parsol 1789 showed that the Parsol 
1789 and octyl methoxycinnamate were both unstable,  breaking down into smaller non-
functional molecules and losing their ability to absorb UVR upon exposure to light [144].  
Similar results were seen with other combinations of sunscreens.  When exposed to SSR, 
a sunscreen containing octyl methoxycinnamate, oxybenzone and octocrylene proved the 
most stable followed by a formulation containing octyl methoxycinnamate, Parsol 1789 
and octylcrylene, then a combination of octyl methoxycinnamate, oxybenzone and octyl 
salicylate and finally a relatively unstable mixture of Parsol 1789 and 4-
methylbenzilidene [145].  It was also found that the addition of octocrylene to any of the 
other tested compounds improved stability [145].  This possible lack of stability of 
sunscreens could result in a loss of photoprotection, and suggests that other new 
photoprotective compounds are needed. 
2.4.2 Natural Product Based Sunscreens   
     Efforts to find more effective and/or photostable sunscreens have taken a number of 
paths, one of which is the investigation of natural products.  Since plants are generally 
exposed to large amounts of ultraviolet radiation, many have evolved defences against 
 39 
the harmful effects of light in the form of secondary metabolites, which may be exploited 
for human use. 
     A body of research exists investigating the photoprotective effects of α-tocopherol, or 
vitamin E.  Vitamin E had been shown to prevent UV-induced skin damage by a 
combination of anti-oxidant and UVB absorptive methods as reviewed by Krol, et. al. 
[146].  Using shaved mice and UVB radiation, topical application of a cream containing 
as little as 1% (w/w) α-tocopherol has been shown to decrease the formation of thymine 
dimers by 43% compared to controls [147].  Further experiments with the same model 
showed that α-tocopherol was more effective in preventing thymine dimer formation than 
ethylhexyl salicylate and oxybenzone, and had similar efficacy to 5% octyl 
methoxycinnamate.  However, in this experiment it appeared that absorbance of the α-
tocopherol by the cell was necessary for the protective effects, suggesting involvement of 
an anti-oxidative mechanism [140].  Topical application of α-tocopherol has also been 
shown to decrease tumor formation.  In mice treated topically with α-tocopherol for three 
weeks prior to UVB exposure, only 42% developed skin cancer 33 weeks post-UVB 
exposure compared to 88% of control mice [148]. 
     Comparison of topical α-tocopherol in vivo to the related compounds γ-tocopherol, δ-
tocopherol showed that all three compounds reduced the formation of thymine dimers 
[140].  The same study showed that α-tocopherol acetate and α-tocopherol methyl ether 
did not affect thymine dimer formation [140].  This study also found that optimal 
prevention of thymine dimer formation required uptake of the tocopherols into the cell 
[140]. 
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     Besides vitamin E, a number of plant extracts have been tested for photoprotective 
properties.  The isoflavones have shown some positive effects in preventing both skin 
cancer and photoaging.  Topical application of genistein (4',5'7-trihydroxyisoflavone) to 
mice 10min to 24hr prior to UVB exposure showed that this isoflavone was effective in 
preventing induction of kinases leading to production of MMP-1, prevented oxidation of 
LDL, reduced both thymine dimer formation and oxidative DNA damage by 90% and 
prevented sunburn [149].  The inhibition by genistein of UVR induced enzyme cascades 
leading to photoaging has also been shown to occur in human skin in vivo [150].  Another 
isoflavone 2',4',7-trihydroxyisoflavone has also been shown to reduce MMP-1 induction 
at both the RNA and protein levels in human fibroblasts [151].   
     Other polyphenols that have been investigated include the flavone apigenin, green tea 
extracts, and cyanidin-3-O-glucoside.  Apigenin has been shown to reduce the incidence 
of cancer by 52% when applied topically to mice 24 hours prior to UVA/B radiation 
[152].  The green tea polyphenols, particularly (-)-epigallocatechin-3-gallate (EGCG) 
have also be tested as topical photoprotectants and have been found to prevent the 
depletion of the anti-oxidant enzymes glutathione peroxidase and catalase as well as GSH 
levels. EGCG also decreased UVB initiated lipid and protein oxidation and inhibited 
phosphorylation of ERK, ANK and p38.  These data seem to suggest that EGCG acts 
primarily through an anti-oxidant mechanism [153].  Finally, pre-treatment of HaCaT 
cells with cyanidin-3-O-glucoside has been shown to decrease UVB induced IL-8, 
procaspase-3 and AP-1 induction [154].  A less related compound, the lignan melanocin 
A has been shown to reduce MMP-9 induction when used to pre-treat HaCaT cells prior 
to UVB exposure [155].   This same compound has also been shown to reduce wrinkling 
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as well as MMP-2 and MMP-9 induction in mice when used as a topical photoprotectant 
[155].      
     In conclusion, various naturally occurring vitamins and polyphenols have shown 
potential for use as topical, broad spectrum sunscreens.  However, methods of protection 
remain to be elucidated and a large number of compounds still need to be investigated to 
find the best option. 
2.4.3 Summary 
     There are currently a variety of commercial sunscreens available to protect skin from 
UVR related damage, including the older UVB screens and newer broad-spectrum 
screens.  The older generation of sunscreens, such as PABA derivatives and cinnamates, 
effectively screen UVB radiation but do not protect from what is now recognized as the 
equally harmful UVA radiation.  Newer sunscreens such as Oxybenzone and mexoryl SX 
protect from both UVA and UVB radiation, but their efficacy and photostability are not 
clear. 
     In efforts to find more effective sunscreens, a number of plant derived natural 
products have been investigated.  Such compounds as α-tocopherol, various polyphenols 
and their sugar derivatives have shown some effectiveness, non-have been marketed to 
date.  One naturally occurring compound that may have potential as a topical sunscreen is 
the flavanol quercetin, which will be discussed in the next section.   
2.5 Quercetin 
2.5.1 Chemistry of Quercetin 
2.5.1.1 Physical Properties of Quercetin 
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    Quercetin (3, 3’, 4’, 5, 7-Pentahydroxyflavone) (Figure 2.9) is a naturally occurring 
polyphenol produced by a variety of plant species [156,157].  It is part of a group of 
phytochemicals called polyphenolic flavanoids, which are characterized by a 
diphenylpropane (C6C3C6) skeleton. Specifically, quercetin is part of a sub-group called 
flavanols which are characterized by a hydroxy group at the 3 carbon, and a double bond 
between carbons 2 and 3 [156].   
 
O
OH
OH
OH
OOH
HO
1
2
3
4
5
6
7
8
1'
2'
3'
4'
5'
6'
 
 
Figure 2.9 - Structure of Quercetin 
 
 
     Quercetin is a solid at room temperature which has a yellow colour in the visible 
spectrum and two strong absorbance bands in the ultraviolet [158].  The maximal UV 
absorbance bands (Figure 2.10) of quercetin occur at 256nm and 368nm with molar 
absorptivity values of 28300 M
-1
cm
-1
 and 28400 M
-1
cm
-1
 respectively [159]. 
  
 
Figure 2.10 UV Spectra of Quercetin in Methanol 
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     Quercetin alone in solution has no fluorescence chromophore, however complexation 
with metals such as Al
3+
 [160,161] or proteins such as albumin [162] results in a strong 
fluorescence chromophore with absorbance at 430nm and emission at 500nm. 
     Quercetin is only sparingly soluble in water but readily soluble in alcohols 
(1g/290mL) as well as soluble in acetic acid and alkaline aqueous solutions [158].  Orally 
administered quercetin has a low toxicity with an LD50 of 160mg/kg in mice [158].  In 
cultured human cells, quercetin has an LD50 of 300µM [163]. 
2.5.1.2 Oxidation of Quercetin 
     Due to its low pKa values (6.74, 9.02 and 11.55) which render it negatively charged at 
neutral pH as well as a high redox potential, quercetin is susceptible to oxidative process 
[164]. As a result, the oxidation products of quercetin are well described in the literature 
[165,166].  A recent article by Zhou reported over 20 oxidation products for quercetin 
[166]. 
     Some of the early work on the oxidation of quercetin was conducted by Westlake et. 
al. working with microbial decomposition of rutin [165].  Three water soluble products 
were found which were identified as protocatechuic acid (3,4-Dihydroxybenzoic Acid), 
phloroglucinol carboxylic acid (2,4,6-Trihydroxybenzoic Acid) and a phloroglucinol 
carboxylic acid - protocatechuic acid ester (quercetin depside) [165], as shown in figure 
2.11. 
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Figure 2.11 - Bacterial oxidation products of quercetin [165] 
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     The compounds shown in figure 2.11 were later generated from quercetin by 
photosensitized oxygenation of quercetin using rose Bengal to generate singlet oxygen 
[167].  The depside was proposed to be formed by addition of singlet oxygen to quercetin 
to form the oxohydroperoxide followed by the loss of carbon monoxide through either a 
five or four membered cyclic oxoperoxide [167,168].  Experiments using 
18
O labelling 
later showed that both base and enzymatically catalyzed oxygenation of quercetin yielded 
the same products, and that the reaction did in fact proceed through the five membered 
cyclic oxoperoxide with the loss of carbon monoxide [169].  Mechanistic studies using 
the copper dependant bacterial enzyme quercetin 2,3-dioxygenase also showed that the 
formation of depside proceeded by 1,3-cycloaddition rather than 1,2-cycloadditon, 
showing that the five membered cyclic oxoperoxide was the correct intermediate, and 
that the copper ion acts as an oxidant towards quercetin [170].  The proposed reaction 
mechanism is shown in Figure 2.12. 
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Figure 2.12 - Proposed mechanism for oxygenation of quercetin [169] 
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     Other studies of the enzymatic oxidation of quercetin have used peroxidase and H2O2 
[171].  This process yielded more than 20 compounds of which were identified 3,4-
dihydroxybenzoic acid; 2,4,6-trihydroxybenzoic acid; methyl 2,4,6-
trihydroxyphenylglyoxylate, 2-(3,4-benzochinoyl 3,5,7-trihydroxy-4H-1-benzopyran-4-
one; 2-(3,4-dihydroxyphenyl)-2-hydro-3,5,7-trihydroxy-3-methoxy-4H-1-benzopyran-4-
one; 2,3-epoxy-2-(3,4-dihydroxyphenyl)-3-[4O-[2-(3-hydroxyphenyl)-3,5,7-]trihydroxy-
4H-1-benzopyran-4-only]-5,7-dihydroxy-4H-1-benzopyran-4-one; and a trimer related to 
the last product [171]. 
     Oxidation of quercetin by bubbling air through a 70% ethanol in water solution of 
quercetin produced three main oxidation products.  These products were identified as 
2,4,6-benzenetriol, 3,4-dihydroxybenzoic acid and 2,4,6-trihydroxybenzoic acid [172].  
The authors propose that formation of the two benzoic acids proceeds through formation 
and subsequent cleavage of quercetin depside as seen in other quercetin oxidation 
reactions.  However, the authors propose that the accepted mechanism of depside 
formation, namely oxidative decarbonylation, is unlikely to proceed under their mild 
conditions and that oxidative decarboxylation is a more likely process, proceeding from 
the keto-tautomer [172]. 
     A similar experiment used horseradish peroxidase and H2O2 treatment to generate 
quercetin oxidation products also yielded at least 20 oxidation products [173].  However, 
the experiment was also conducted with the addition of glutathione as a radical 
scavenger.  The addition of GSH resulted in the production of only two products which 
were identified as the 6-glutathionylquercetin and 8-glutathionylquercetin, with the 
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adducts forming on the A ring.  The authors propose a mechanism wherein the quercetin 
semi-quinone is oxidized to the o-quinone which isomerizes to the p-quinone methide 
which has electrophilic character at the C6 and C8 positions [173].  A comparison of the 
GSH adducts formed upon oxidation of several structurally related compounds supported 
this mechanism, as it showed that only those compounds containing a catechol group on 
the B-ring, and therefore capable of forming the o- and p-quinone, showed substitution of 
GSH on the A ring [174].  Similar results were seen when tyrosinase was used to 
generate the unstable quercetin o-quinone, with 6- and 8-gluathionylquercetin being 
formed.  In addition, these adducts were shown to be unstable and capable of inter-
conversion [175]. The position of GSH adduct formation has also been shown to be pH 
dependant.  At pH 7.0, the C6 and C8 adducts described above form, but as pH increases 
the amount of C6 and C8 adducts decreases until at pH ≥ 9.5, they are completely 
replaced by 2',5'-digluathionyl quercetin and 2',5',6'-triglutathionyl quercetin.  In contrast, 
at pH < 7 two products are formed, both of which have added one GSH and one H2O.  
The authors attribute the addition of GSH to the B ring under alkali conditions to the loss 
of the proton at the C3 hydroxyl, preventing the formation of the quinone methide [176].   
     Studies comparing GSH binding to quercetin oxidation products with that of other 
cellular thiols have shown that GSH is not necessarily the favoured scavenger.  When 
GSH, cysteine and N-acetylcysteine were used the favoured conjugates were 6- and 8-
cysteinylquercetin.  However, since GSH is present in much higher concentrations in the 
cell than cysteine or N-acetylcysteine, the GSH adducts are likely still the favoured 
conjugates in vivo [177].  
 47 
     Electrochemical oxidation studies with quercetin have shown that there are three 
distinct oxidation events which can occur at pH 7.0.  The first oxidation at 150mV occurs 
at the catechol group on the B ring, the second at 500mV corresponds to oxidation of the 
hydroxyl group at C3, and the final oxidation occurs at the 5,7-dihydroxy substiuent on 
the A ring [178].  This study identified 2 oxidation products, distinct from the expected 
3,4-dihydroxybenzoic acid and 2,4,6-trihydroxybenzoic acid, but the products were not 
identified [178].  In contrast a later electrochemical oxidation study of quercetin showed 
the production of 18 different products.  The expected 3,4-dihydroxybenzoic acid and 
2,4,6-trihydroxybenzoic acid were present along with their esters as were the depside and 
its ester and 2,4,6-benzenetriol.  Other products included 3,4-dihydroxy- and 2,4,6-
trihydroxy-phenylglyoxylic acid, and taxifolin, the C2-C3 saturated form of quercetin.  
Also present were 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-benzofuran-3-one, in 
which the C ring has become a furan, quercetin chalcone (3-(3,4-dihydroxy-phenyl)-2-
hydroxy-1-(2,4,6-trihydroxy-phenyl)-propenone, resulting from cleavage of the 1,2 
heteroatomic bond in the C ring, as well as 2-(3,4-dihydroxyphenyl)-2-
(hydroxyl(ethoxy)-5,7 - dihydroxy-chroman-3,4-dione and 2-[carboxy-(3,4-
dihydroxyphenyl)-hydroxy-methoxy]-4,6-dihydroxybenzoic acid.  Finally a dimer that 
had formed between the catechol moiety and the C2-C3 double bond was detected [179].  
In addition to the structural data, a number of possible mechanisms were proposed [179].       
     The formation of the quercetin dimer was also investigated using 2,3'-
azobisisobutyronitrile (AIBN) as the oxidizing agent.  This study showed that in addition 
to the C2-C3 double bond, a free C3 hydroxyl is essential for dimer formation [180]. 
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Quercetin oxidation products generated using the radical generator AIBN produce similar 
products to those seen when electrochemical oxidation is used, although with less variety.  
The oxidation of quercetin by AIBN in acetonitrile produced four compounds.  These 
included the benzofuran derivative 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-
benzofuran-3-one and the depside.  The authors proposed that rather than the depside 
being formed through the five membered cyclic oxoperoxide, both the depside and the 
benzofuran were formed through a common carbocation intermediate [181].  The other 
products found by AIBN oxidation were methyl 3,4-dihydroxyphenylglyoxylate and the 
quercetin dimer [181].  The products of lipid radical reactions with quercetin have also 
been studied and identified as the depside and the quercetin dimer [182].  Mechanistic 
studies of the chemical oxidation of quercetin in protic and aprotic solvents using 
diphenylpicrylhydrazyl and ceric ammonium nitrate as radical generators as well as under 
auto-oxidative conditions have also been conducted.  These studies have shown that the 
first step in the reaction following hydrogen abstraction to form the radical species is 
rapid disproportionation to form the o-quinone which rapidely establishes an equilibrium 
with the quinone methide [183]. 
     The oxidation of quercetin and the mechanisms which result in the observed products 
are complex and seem to be somewhat dependant on the oxidant species and the solvent 
as well as the presence of radical scavengers.  As a result the mechanisms involved in the 
formation of the oxidation products are still a matter of some debate.  However, even if 
the mechanisms involved are not fully known, the resulting oxidation products from a 
wide variety of oxidation methods are fairly well characterized and have been 
summarized by Zhou [166].       
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2.5.1.3 Photochemistry of Quercetin 
     Due to the strong absorbance of quercetin in the UVR range [159] the question of 
quercetin’s photochemistry is pertinent.  Work has been done which showed that 
quercetin in an ethanol solution disappeared within 18 to 37 hours, as monitored by the 
UV absorption bands when exposed to UVC radiation [184].  Other studies on the 
stability of quercetin in alcohol solution, in this case methanol, found that quercetin 
absorbance decreased by 17% after 15 hours of combined UVA and UVB radiation 
[185].  In both of these experiments, air was bubbled through the alcohol solutions, 
raising the possibility of photoinduced singlet oxygen resulting in an oxidative 
decomposition [184,185].  In contrast, quercetin appeared to be resistant to photolysis 
when dissolved in 1:1 benzene:isopropanol and exposed to a mercury lamp which the 
authors suggested could be the result of tautomerization and deprotonation of the excited 
state or intramolecular quenching, all of which would increase photostability [186].    
     Exposure of quercetin deposited on cellulose to combined UVA/UVB radiation also 
resulted in photobleaching, but the extent of this effect was not quantitated [185].  
Exposure of wool dyed with quercetin to combined UVA/UVB radiation also showed 
decomposition of quercetin , with 3,4-dihydroxybenzoic acid being identified as a 
degradation product, presumably being formed through the depside.  The expected 2,4,6-
trihydroxybenzoic acid was not observed, though this was attributed to loss during an 
acid extraction process [187]. 
2.5.2 Dietary Intake of Quercetin 
2.5.2.1 Sources of Quercetin 
     Quercetin is found in many members of the plant kingdom, including many edible 
species, and the estimated daily intake of quercetin for North Americans is 25 mg/day 
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[188].  Quercetin is found in high levels in onion, lettuce, broccoli, cranberries and apple 
skins [156].  Quercetin, along with other flavanoids, is also found in a number of 
common beverages including tea, beer and wine [188].   
     Quercetin is most commonly found in plants, and ingested, as a glycoside with the 
linkage to the sugar occurring through the hydroxyl group at the C3 position to form 
quercetin-3-O-glycoside [188].  The most commonly consumed quercetin glycosides are 
rutin (quercetin bound to rutinose) and quercetrin (quercetin bound to rhamnose) [188]. 
2.5.2.2 Absorption of Quercetin 
     Since most dietary flavanoids are ingested as the glycosides, absorption of quercetin 
necessarily involves absorption of the quercetin glycosides.  Due to their high molecular 
weight and their generally hydrophilic nature, ingested quercetin glycosides largely pass 
unaltered through the small intestine [188], with little or no absorption of the glycoside 
occurring at this point [189].  However, it has been shown in humans that rutin is 
absorbed in the distal small intestine or colon [190,191].  The literature further 
demonstrates that in the lower small intestine and colon, the quercetin glycosides are 
hydrolysed prior to absorption and that it is in fact the aglycone form of quercetin which 
is absorbed [188,191].  This cleavage of the sugar group appears to be primarily caused 
by glycosidases produced by intestinal microflora [188].  However, there is also some 
evidence that some flavanoid glycosides can be hydrolysed in the brush border of 
mammalian small intestine by lactase phloridzin hydrolase, following which the aglycone 
can be absorbed [189].  There is also some evidence for transport of rutin quercetin-3-
glucoside across the jejunum following infusion of isolated rat small intestine when gut 
microflora were not present [192]. 
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     Although quercetin in plants is mainly encountered in a glycated form, a small amount 
of aglycone may be present [188].  Also, quercetin aglycone is available as a dietary 
supplement from a number of manufacturers [157,188].  In contrast to the glycosides of 
quercetin, quercetin aglycone is absorbed in the upper portion of the duodenum [191].  
Quercetin is lipophilic enough in character that absorption does not require active 
transport, and absorption in humans is in the range of 36 to 54% [189].  Once in the 
circulatory system, quercetin is extensively protein bound with 99.1% protein binding 
being reported in humans [189,191,193].  In addition, it has been shown that topically 
applied quercetin can effectively cross the skin with 50% of the dose appearing in the 
dermis after 12 hours [194]. 
2.5.2.3 Quercetin Metabolism 
     Although quercetin aglycone is absorbed from the intestine following oral dosing with 
quercetin aglycone or a quercetin glycone such as rutin, little or no free quercetin is found 
in the blood [189].  This is due to quercetin’s high degree of plasma protein binding 
(99.1%) [189,191,193] and rapid metabolism.   
     Due to the presence of 5 hydroxyl groups on quercetin, the cytochrome P450, or CYP 
enzymes do not act upon it and no CYP mediated metabolism of quercetin is observed in 
vivo [195,196].  In contrast, the quercetin related flavanoids kaempferol, which lacks the 
3' hydroxyl, and tamarixetin, which has a 4' methoxy group instead of a hydroxyl, are 
metabolized to quercetin by CYPs 1A2, 3A4 and 2C9 [195]. 
     Even though quercetin is not metabolized by the cytochrome P450’s, quercetin does 
have effects on some P450 enzymes.  In human liver microsome samples, quercetin, 
along with other flavanoids, inhibited CYP 1A [197].  Studies using galangin, which 
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lacks the catechol moiety, have shown that it is hydroxylation at the 3 and 5 positions that 
is important for this inhibition [198].  Quercetin also showed a biphasic activity for CYP 
3A4 and CYP 3A3, activating these enzymes at low concentrations and inhibiting their 
activity at higher concentrations [197].  In addition quercetin has been shown to be an 
efficient inhibitor of Cyp 2B1 from rat microsomes, showing greater inhibition than the 
related compounds catechin, epigallo-catechin gallate, diosmin, and naringenin [199].         
     The abundance of hydroxyl groups on quercetin which make it resistant to phase I 
metabolism also makes it highly susceptible to phase II conjugation.  Free quercetin is 
not found in the blood in either rat or human subjects, but a large number of quercetin 
conjugates are found in plasma and urine [189,190,200,201].  The major quercetin 
metabolite found in urine following intraperitoneal administration of quercetin to rats  is 
3'-O-methylquercetin, the formation of which appears in vivo to prevent the carcinogenic 
potential of quercetin seen in vitro [200].  An analysis of human urine following the 
consumption of cooked onions showed a large number of metabolites including three 
quercetin-diglucuronides, methyl-quercetin-diglucuronide, two quercetin-
monoglucuronides, two quercetin-glucoside sulphates, quercetin-monoglucuronide 
sulphate, four methyl-quercetin-monoglucuronides and methyl-quercetin [201]. 
     In vitro cell culture studies of quercetin metabolism have also been performed, and 
have yielded more detailed metabolite structures.  Treatment of mouse melanoma cells 
with quercetin resulted in the production of two glutathione adducts with addition 
occurring at the 6 and 8 positions of quercetin, with addition the 8 position occurring at a 
higher yield [202].   
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     Treatment of rat microsomes from the liver and small intestine with quercetin 
produced a number of sulphonated, methylated and glucuronidated metabolites.  In rat 
liver, 6% of the administered quercetin was methylated (65% at the 3' position, 35% at 
the 4'), 14% was sulphonated (12% at the 7, 88% at the 3') and 18% was glucuronidated 
(40% at 7, 42% at 3', 18% at 4').  In rat small intestine microsomes, 4% was methylated 
(67% at 3', 33% at 4'), 25% was glucuronidated (9% at 3, 41% at 7, 46% at 3' and 4% at 
the 4').  No sulphonation products were found in the small intestine microsomes [203].  
The same experiment using human liver and intestinal microsomes showed similar results 
with some differences.  Human liver microsomes produced 5% methylation (66% at 3', 
34% at the 4'), 22% glucuronidation (13% at 3, 65% at 7, 19% at 3' and 3% at 4').  
Surprisingly, human liver microsomes, like rat intestinal microsomes, produced no 
sulphonate conjugates of quercetin.  Human intestinal microsomes produced the greatest 
variety of quercetin conjugates with 1% methylation (62% at 3' and 38% at 4'), 5% 
sulphonation (12% at 7 and 88% at 3'), and 61% glucuronidation (20% at 3, 4% at 7, 49% 
at 3' and 27% at 4') [203]. 
     Treatment of human fibroblast cultures with quercetin resulted in the formation of two 
metabolites, a 2' glutathione-quercetin conjugate and a quercetin quinone/quinone 
methide – glutathione conjugate [204].  The same study showed that treatment of 
fibroblasts with 3'-O-methyl quercetin or 4'-O-methyl quercetin resulted in formation of 
similar products, suggesting that demethylation of these compounds is the initial reaction 
[204].         
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2.5.3 Biological Effects of Quercetin 
2.5.3.1 Antioxidant Properties of Quercetin 
     As discussed briefly in section 2.5.1.2, as a result of the abundance of hydroxyl groups 
on quercetin, the low pKa values and high redox potentials quercetin is oxidatively labile 
[164].  Quercetin rapidly reacts with radicals, such as the azide radical, to form a 
quercetin radical species with a rate constant 6.6x10
-9
 dm
3
mol
-1
s
-1
 [79].  The resulting 
radical species is quite stable with a decay rate constant of 3.4x10
-6
 dm
3
mol
-1
s
-1
[79].  
These properties make quercetin an effective anti-oxidant, and the anti-oxidative 
properties of quercetin have been extensively studied. 
     A variety of methods have been used to determine the anti-oxidant capacity of 
quercetin.  Using the Trolox Equivalent Antioxidant Capacity (TEAC) test which 
measures the ability of a compound to scavenge the ABTS
.+
 radical, 1mM quercetin has 
been found to be equivalent to 4.7mM of the vitamin E derivative Trolox [156].  This 
value makes quercetin among the most effective antioxidants found among the 
polyphenols found in tea extracts [205].  However, another study using the same method 
found an equivalency of only 2.5 [206].  These values are determined over longer term 
exposure of quercetin to the radical species, but an assessment of the fast reaction 
kinetics results in different numbers, with Trolox equivalences of 1.01 and 1.21 being 
determined for the reaction at 0.1 sec and 2 sec respectively [207].    
     Another system which has been used to determine the anti-oxidant capacity of 
quercetin is the scavenging of 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) radicals, which 
resulted in a stoichiometry of 2.35 radicals per quercetin molecule in dimethylformamide 
and 3.19 in methanol [183].  In addition, quercetin has been shown to scavenge 3.7 Fe
3+
 
ions reduced per molecule for the Ferric Reducing Antioxidant Power assay (FRAP) 
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[206].  Finally quercetin has been found to have an IC50 of 0.154µM against peroxynitrite 
oxidation of dihydrorhodamine [208].   
     Quercetin has also been shown to be an effective scavenger of a variety of reactive 
oxygen species including hydrogen peroxide [174], and superoxide [209].  The rate 
constants for these, and other scavenging reactions, have been determined to be 
.
OH = 
43x10
8
M
-1
s
-1
, t-butyloxide = 25x10
8
M
-1
s
-1
, lipid peroxide = 0.18x10
8
M
-1
s
-1
 and 
superoxide = 0.0009x10
8
M
-1
s
-1
 [209]. 
     From a biological point of view, the most significant anti-oxidant effect of quercetin 
may be the prevention of lipid peroxidation, and a number of studies have looked at this 
property with varying results.  Looking at the formation of malondialdehyde (MDA) 
formation initiated by Fe
2+
 and using the thiobarbituric acid reactive substances (TBARS) 
method to measure oxidation of flax oil, quercetin was determined to have an IC50 of 
1.7µM [210].  This is similar, though lower than the IC50 determined by TBARS in the 
auto-oxidation of rat cerebral membranes where a value of 3.09µM was determined 
[211], and both these values were much lower than TBARS IC50 of 17.6µM determined 
for FeSO4 peroxidation of microsomes [212].  Other methods of determining IC50 values 
for quercetin vary even more widely.  Using conjugated diene formation as a measure of 
iron initiated linolate peroxidation has given an IC50 = 28.61µM [211], measurement of t-
butyl-hydroperoxide initiated chemiluminesence of rat liver homogenates gave an IC50 of 
200µM [213]. 
     Stoichiometricly, quercetin has been found to protect flax oil against iron oxidation by 
chelating 3 molecules of Fe
2+
 per molecule of quercetin [210].  This value is comparable 
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to the stoichiometry of 3.5 radicals trapped per quercetin molecule of quercetin when 
preventing AMVN-catalyzed oxidation of methyl linolate [214].    
     Minimal effective doses of quercetin for the protection of lipids from oxidative 
damage have also been determined.  Quercetin protection of lipoproteins from oxidation 
by the radical generator AAPH required a minimum concentration of 2µM to be effective 
[215].  This value is comparable to the value of 5µM needed to prevent peroxidation of 
low density lipoprotein (LDL) caused by copper ions [216].  However, both these values 
differ greatly from the minimum effective dose of 82.1µM quercetin found necessary to 
scavenge the alkylperoxyl radical products of lipid peroxidation [217].  
     In more complete biological systems, quercetin has also been found to be an effective 
antioxidant.  In skin cells, when GSH synthesis is inhibited by buthione sulfoximine, 
depletion of GSH leads to the accumulation of peroxides in the cell which lead to cell 
death.  Treatment of cultured fibroblasts with quercetin, at an EC50 of 30 to 40µM, 
significantly reduced the level of cell death, while not altering the GSH levels.  This 
suggests that quercetin was effectively taking up the radical scavenging duties of the 
depleted GSH [218].  Similar results were also found in cultured nerve cells, where pre-
treatment with a minimal effective dose of 10µM quercetin protected the cells from H2O2 
induced neurodegeneration [219]. 
     The large variation seen in the IC50, stoichiometry, and minimal effective dose 
numbers found for quercetin in the literature is a cause of some concern.  However, these 
differences may be explained by the fact that the studies use a variety of endpoints, 
oxidation initiators, and reaction media to determine the numbers.  As a result the anti-
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oxidant mechanism, availability of quercetin and degree of incorporation of quercetin 
into membranes may all affect the anti-oxidant values. 
     A comparison of the anti-oxidant capacity of quercetin to that of other flavonoids has 
shown mixed results.  In a study of the anti-oxidant effects of various polyphenols against 
Cu
2+
 induced damage to LDL, quercetin proved to the most effective of the compounds 
tested [220].  The authors concluded that quercetin has a large number of reactive centres 
and as such is more reactive to reactive oxygen species than other compounds like the 
quercetin glycoside rutin [221].  It is also supported by the fact that quercetin has a higher 
TEAC value than most flavanoids and their glycosides [156].  In contrast, quercetin was 
found to be less effective than rutin in protecting linoleic acid from auto-oxidation, 
perhaps because of differences in solubility [222]. 
     The comparison of quercetin to other flavanoids in terms of anti-oxidant capacity has 
led to some conclusions about the structural factors affecting this ability.  The structural 
components of the flavanoids which increase anti-oxidative capacity appear to be the 
catechol group on the B-ring, the double bond between carbons 2 and 3, and the presence 
of a 3 and 5 hydroxyl on the A ring along with the C-4 oxo-group, all of which quercetin 
has [156].  These structural features allow quercetin to suppress lipid peroxidation at 
three points in the oxidative process, the formation of superoxide radicals which can be 
scavenged, the generation of hydroxyl radicals and the formation of lipid peroxyl radicals 
[223].    
     Although quercetin is primarily thought of as an anti-oxidant, it can act as a pro-
oxidant as well.  In rat liver microsomes, at concentrations above 100µM, quercetin has 
been shown to increase the generation of hydroxyl radicals from H2O2 in the presence of 
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Fe
3+
-EDTA by eight fold.  However, this effect was not seen with Fe
3+
-citrate or Fe
3+
-
ADP in the presence of H2O2 [224].  There is some evidence that this pro-oxidant effect 
of quercetin occurs through the o-quinone or semi-quinone product of quercetin oxidation 
which could result in the formation of superoxide or depletion of cellular GSH [225]. 
2.5.3.2 Enzyme Related Effects of Quercetin 
     In addition to the anti-oxidant properties of quercetin, there are a number of other 
biological effects as well.  In addition to its anti-oxidant capacity, quercetin can affect the 
cell’s own defences against oxidative stress [226,227].  Quercetin can also modify the 
activity of a number of CYP enzymes as discussed in section 4.2.3 [197-199].  Finally, 
quercetin can modify a number of enzyme cascade pathways [228-230]. 
     In female rats, quercetin has been shown to reduce the activity of glutathione 
reductase, catalase and glutathione peroxidase in red blood cells while still reducing the 
overall oxidative stress, suggesting that a feedback mechanism exists which down 
regulates the expression of anti-oxidant enzymes when quercetin is present [226].  In 
contrast to this down regulation of anti-oxidant enzymes, quercetin has also been found to 
increase synthesis of γ-glutamylcysteine transferase, an important enzyme in the 
synthesis of glutathione, resulting in an increase in cellular glutathione levels [227].  
     In the human endothelial cell line ECV304 quercetin has been shown to down regulate 
TNF-α induced ICAM-1 expression in a dose dependant manner with significant 
deceases seen from 1 to 50 µM quercetin.  This down regulation seems to be controlled 
through the inhibition of AP-1 activation and inhibition of the JNK pathway [228].  This 
inhibition of ICAM-1 expression leads to a decrease in inflammation, but inhibition of 
AP-1 may also be tumor promoting as it inhibits apoptosis [112,231,232].  
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     Quercetin has also been shown to affect ERK, though what those effects are remains 
unclear.  In cultured neuronal cells, quercetin and its methylated metabolites have been 
shown to inhibit the pro-survival signal enzymes ERK and Akt/PKB which leads to an 
induction of neuronal cell death through increased activity of caspase-3 in a dose and 
time dependant manner with effects seen from 10 to 30uM quercetin [233].  In contrast, 
in mouse macrophage cells, 25, 50 and 100µM quercetin has been shown to induce 
phosphorylation of ERK, but not JNK.  This increase in ERK activity induces heme-
oxygenase-1 activity at 50µM quercetin which protected against H2O2 induced apoptosis 
[229].  In addition, in myoblast cells treated with 10 to 20µM quercetin for 1 hour, or 
with 1 and 3 µM quercetin for 18 hours gave significant protection from H2O2 [230].  
This protection appeared to occur through increased phosphorylation of the anti-apoptotic 
proteins Akt and ERK1/2 [230].   
     Finally, Nagata et. al showed that treatment of cultured melanocytes with 5µM, 10µM 
or 20µM quercetin for up to seven days resulted in an increased production of melanin in 
the absence of UV light, through activation, but not induction, of tyrosinase [234].  This 
same group also showed that this effect occurs in a reconstructed three-dimensional 
epidermal model when quercetin was added to the culture media [235].  These results 
suggest that quercetin may protect against UVR damage by a number of mechanisms.   
2.5.3.3 Photoprotection by Quercetin 
     As previously stated in section 4.2, quercetin is produced by a wide variety of plant 
species, usually as a glucoside [156,188].  In many of these species, quercetin is 
upregulated in repose to UV radiation.  In the leaves of Brassica napus (canola) plants 
three quercetin glucosides and three kaempferol (no 3' hydroxyl, only a 4') glucosides 
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were upregulated in response to UVB radiation [236].  These were identified as 
quercetin-3-O-sophoroside, quercetin-3-O-sophoroside-7-O-glucoside, quercetin-3-O-
sophoroside-7-O-glucoside-caffeoyl ester, kaempferol-3-O-sophoroside, kaempferol-3-
O-sophoroside-7-O-glucoside and kaempferol-3-O-sophoroside-7-O-glucoside-
coumaroyl ester [236].  This increase in flavanoids correlated with increased UVB 
protection in the form of a decreased degradation of the D1 protein of photosystem II 
[237].   
     Using wild type and transgenic strains Petunia axillaris, Ryan, et. al. found that 
exposure to UVB resulted in an increase in total flavonol content in the leaves, and in 
particular an increase in the quercetin derivative to kaempferol derivative ratio compared 
to non-UVB exposed plants.  The change in ratio and the fact that increased anthocyanin 
content did not appear to be protective suggests that it is the quercetin derivatives that are 
most photoprotective [238].  This same group also showed that plants with an increased 
quercetin to kaempferol ratio due to UVB exposure had faster growth rate compared to 
those mutants which did not produce quercetin in response to UVB, further suggesting a 
photoprotective role for quercetin [239]. 
     Similar responses have been seen in the skin of apples, Malus domestica.  In a 
comparison of the skins of two cultivars of apple fruit it was shown that Granny Smith 
apples did not increase the levels of quercetin glycosides in sun exposed fruit while 
Braeburn apples showed a significant increase in quercetin glycosides in sun exposed 
portions of fruit skins [240].  The same study found that this increase in quercetin 
glycosides in Braeburn skin resulted in less UVB induced damage to the apples 
photosynthetic apparatus [240].  Another study in the Antonovka cultivar of apples found 
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that in shaded apples cuticular phenolics were responsible for UVA/UVB absorption, 
while in sun exposed apples, UVA absorption was primarily due to quercetin glycosides 
in the vacuoles.  From this the authors concluded that a build up of quercetin in cells just 
below the cuticle is a dominant factor in the apples long term adaptation to high sun 
levels [241].  However, the mechanism by which quercetin protects the plants is not 
clear. 
     The photoprotective effects of quercetin glycosides have prompted a number of 
investigations into possible photoprotective effects of quercetin in animals.  Since skin 
cancer [8-10] and immunosuppression [15,113] are two of the most significant effects of 
UVR exposure, the ability of quercetin to protect against these effects has been 
investigated.  Steernberg, et. al. reported that in SKH hairless mice exposed to UVR for 
up to 17 weeks and fed a diet containing 4% quercetin by weight, no affect on the onset 
or growth of non-melanomic skin carcinomas was observed [242,243].  However, the 
quercetin treatment did prevent the UVR induced contact hypersensitivity suppression 
seen in control mice, likely by preventing the decrease in epidermal Langerhan's cells 
seen in unprotected mice exposed to UVR [242,243]. 
     Because of the strong antioxidant capacity of quercetin, the ability of quercetin to 
prevent UVR induced oxidative damage has also been assessed.  Quercetin was found to 
inhibit the peroxidation of phosphatidylcholine liposomes by UVC radiation at an IC50 of 
6.24µM.  In the same study, to assess the use of quercetin topically, the authors found 
that less than 1% of topically applied quercetin crossed the epidermis of excised human 
skin in 24 hours [244].  Another study using hairless mice, but treating with UVB found 
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that topical quercetin prevented UVB induced myeloperoxidase activity, GSH depletion 
and proteinase secretion, all markers of oxidative stress [245].   
     Using Sprague-Dawley rats exposed to UVA and intraperitoneal injections rather than 
topical application, Inal, et. al. found that animals given of 50mg/kg quercetin had 
reduced levels of malondialdehyde (MDA), a marker of oxidative stress, compared to 
those rats treated with UVA alone while GSH levels were unchanged [246,247].  The 
same studies also found that UVA significantly reduced hepatic levels of superoxide 
dismutase and catalase, but that quercetin partially prevent this reduction [246,247].  
Similar results were found when rats were fed 50mg/kg quercetin in their diets with 
significant decreases in MDA levels and prevention of UVA induced reduction of 
superoxide dismutase and catalase being observed [248].   
     Quercetin has also been shown to affect the induction of matrix metallo protease-1 
(MMP-1), a marker of photoaging.  Using human fibroblasts and the naturally occurring 
quercetin derivative quercetin-3O-β-D-(6"-feruloyl)-galactopyranoside, Moon, et. al. 
showed that UVB-induced expression of MMP-1 was reduced in a dose dependant 
manner by the flavonol glycoside [249].  This same group also showed that quercetin 
aglycone inhibited MMP-1 activity with an IC50 of 39.6µM and that in fibroblasts, 
quercetin inhibited the chemically induced production of MMP-1, likely through the 
inhibition ERK and MAPK activation [250]. 
     Finally, quercetin has been shown to be effective in the prevention of pharmaceutical 
photosensitization.  The NSAID ketoprofen is used as both a topical [251] and as a oral 
[252] analgesic.  However, ketoprofen, oral or topical, can cause photosensitization 
through the formation of radical species following absorption of UVR [251,253].  When 
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exposed to UVR, ketoprofen can cause lipid peroxidation, DNA adduct formation, and a 
photoallergic reaction [251].  Nakajima, et. al. have demonstrated that quercetin strongly 
suppresses free radical generation by light exposed ketoprofen, suggesting that quercetin 
may be effective in protecting against photosensitization [252].   
 2.5.4 Summary 
     The yellow polyphenol quercetin is a sparingly water soluble plant derived flavanol 
with absorption bands in the UVC and UVA but no fluorescence chromophores.  
Quercetin is also susceptible to oxidation and up to 20 oxidation products have been 
observed.  Of these twenty products, the most commonly observed and most abundant are 
protocatechuic acid (3,4-Dihydroxybenzoic Acid), phloroglucinol carboxylic acid (2,4,6-
Trihydroxybenzoic Acid) and a phloroglucinol carboxylic acid - protocatechuic acid ester 
(quercetin depside) which are generated in a number of oxidation systems.  Addition of 
radical scavengers such as GSH to quercetin oxidation systems has shown that GSH adds 
at the C6 and C8 positions, suggesting that the quercetin semi-quinone is oxidized to the 
o-quinone which isomerizes to the p-quinone methide which has electrophilic character at 
the C6 and C8 positions.  However, due to the complex nature of quercetin oxidation, the 
complete mechanism is still not clear.   
     Limited work has also been done on the photochemical properties of quercetin.  
Although photobleaching in solution has been observed, this was in the presence of 
bubbled oxygen suggesting the possibility of oxidation by photo-induced singlet oxygen.  
Photobleaching of quercetin on deposited on cellulose has also been observed, resulting 
in the production of 3,4-dihydroxybenzoic acid being identified as a degradation product, 
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presumably being formed through the depside.  However, to date the identity of the 
photodecomposition products of quercetin, if any, have not been reported. 
     Quercetin is generally found in plants as a glycoside and is high concentrations in 
food plants such as onion, lettuce, broccoli, cranberries and apple skins.  As a result, most 
North Americans have a fairly high rate of quercetin intake, estimated at 25mg/day.  
Following ingestion quercetin glycosides pass through the small intestine to the colon 
where hydrolysis of the sugar occurs to give quercetin aglycone which is absorbed.  In 
addition to the glycosides, many plants also contain small amounts of quercetin aglycone 
which is passively absorbed in the upper portion of the duodenum.  Once in circulation, 
quercetin is highly protein bound. 
     Due to the five hydroxyl groups found on quercetin, the CYP enzymes do not act on 
it.  However, quercetin has been found to modulate the activity of CYP 1A, 3A4, 3A3 
and Cyp 2B1 in rats.  Although not metabolized by the CYP enzymes, quercetin is 
subject to conjugation by phase II enzymes.  The conjugation products of quercetin 
include glucutronidates, methylates, sulphonates, and multiple conjugates involving any 
combination at a variety of positions.  Following conjugation, quercetin is usually 
excreted in the urine. 
     Since quercetin is readily oxidized, it is also an effective anti-oxidant and a large 
amount of research has been done on this property.  A number of anti-oxidant 
measurement systems have been used to determine just how effective an anti-oxidant 
quercetin is and have resulted in a range of values.  Trolox equivalent values of 4.7mM 
and 2.5mM have been reported as well as IC50 values ranging from 1.7µM to 200µM.  
Stoichiometric values for quercetin’s anti-oxidant potential are less variable but still 
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range from 2.35 to 3.7 radicals per molecule.  This anti-oxidant values are derived from a 
variety of analytical techniques in a variety of systems, but clearly no consensus exists on 
how effective an anti-oxidant quercetin is.  In addition to the anti-oxidant capacity of 
quercetin, the structural components that make it an effective radical scavenger have been 
determined which have been shown to be the catechol group on the B-ring, the double 
bond between carbons 2 and 3, and the presence of a 3 hydroxyl and a 5 hydroxyl on the 
A ring along with the C-4 oxo-group.  
     Quercetin also has a number of biological effects in addition to its anti-oxidant 
properties.  In rats, quercetin has been shown to decrease endogenous anti-oxidant 
enzyme levels while increasing levels of glutathione as well as inhibiting AP-1 and the 
JNK pathway.  In addition, quercetin has been shown to cause up-regulation of melanin 
synthesis, suggesting a possible mechanism of UVR protection. 
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     Quercetin, quercetin derivatives and their glucosides have been shown to be 
upregulated in a number of plant species in response to UVR exposure including 
Brassica napus, Petunia axillari, and Malus domestica.  Although the extract mechanism 
of action remains unclear, it is believed that this up-regulation results in a photoprotective 
effect.  Quercetin administered by a number of routes has also been investigated for its 
photoprotective effects in mammals.  Oral quercetin did not prevent onset of NMSC’s but 
did prevent contact hypersensitivity in mice while topical and IP administered quercetin 
prevented oxidative stress in skin.  In addition quercetin has also been shown to reduce 
expression of the markers of photoaging and prevent photosensitization by the NSAID 
ketoprofen. 
     In summary, the plant polyphenol quercetin has a number of physiochemical 
properties that result in it being a strong anti-oxidant as well as effecting enzyme levels 
and showing various photoprotective properties.  These findings suggest that a topically 
applied formulation of quercetin may be effective in reducing the negative results of 
UVR exposure.  The investigation of this possible means of sun protection is the focus of 
the research presented here. 
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3. Hypothesis and Objectives 
Due to the deleterious effects of UVA and UVB radiation and the uncertainties associated 
with currently available commercial sunscreens, investigations into a new, natural 
product based sunscreen may prove useful.  We hypothesise that quercetin (3,3',4',5,7-
Pentahydroxyflavone), when applied topically, provides protection from damage due to 
UVB and UVA radiation by UVB/UVA radiation absorption, antioxidant activity and 
interference with cellular signalling pathways.  
In order to test this hypothesis, four major objectives for this research project were 
established. 
3.1 Objective 1 – Determination of the antioxidant capacity of quercetin in a 
simulated membrane system 
One of the major mechanisms by which UVR causes deleterious effects in the skin is 
through the generation of reactive oxygen species [49,50].  As such, clearly defining the 
anti-oxidant capacity of quercetin against both chemical oxidants and UVR is important 
for determining its ability to protect against UVR induced skin damage. 
3.2 Objective 2 – Determination of the photo-stability of quercetin and identification 
of quercetins photodecomposition products 
One of the concerns about some of the currently available sunscreens is the question of 
photostability.  If the sunscreen breaks down on exposure to UVR the effectiveness is 
likely to decrease and the possibility of toxic product formation exists.  As such it is 
important to access the photostability of quercetin and to identify any decomposition 
products. 
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3.3 Objective 3 – Determination of quercetin’s ability to prevent photo-sensitization 
due to decomposition of the xenobiotic ketoprofen 
In addition to directly causing harmful effects in the skin, UVR can also react with 
exogenous compounds such as pharmaceuticals to cause damage.  One such 
pharmaceutical is the NSAID ketoprofen which has been shown to cause 
photosensitization [251,253].  As such, the ability of quercetin to prevent photo-
sensitization using ketoprofen as a model needs to be determined.  
3.4 Objective 4 – Determination of the effect of quercetin on biomarkers of photo-
aging and photo-induced DNA damage 
Two of the major endpoints of UVR induced damage are photoaging and damage to 
DNA.  Assessment of quercetin's ability to prevent both DNA damage and photoaging 
are therefore necessary for determining it’s suitability as a sunscreen. 
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6.1 Abstract 
     The flavonol quercetin is currently being investigated for its potential as a topical skin 
photoprotectant. Quercetin can protect against the UV-mediated breakdown of 
ketoprofen, a non-steroidal anti-inflammatory drug associated with skin photosensitivity. 
We have previously examined the photostability of quercetin in methanol to UVA and 
UVB radiation and have determined that a small conversion (<10%) to C-ring breakdown 
products occurs over 24 hours. The major photoproducts from either UVA or UVB 
radiation were determined to be 2, 4, 6-trihydroxybenzaldehyde, 2-(3', 4'-
dihydroxybenzoyloxy)-4, 6-dihydroxybenzoic acid and 3, 4-dihydroxyphenylethanol.  
This process was dramatically accelerated by the addition of a triplet sensitizer such as 
benzophenone. In the present work, we determined whether two structural analogs of 
benzophenone, ketoprofen and the sunscreen ingredient oxybenzone, could catalyze UV-
mediated quercetin decomposition. We determined that ketoprofen catalyzes UV-
mediated decomposition of quercetin in a similar manner to benzophenone. Conversely, 
oxybenzone does not catalyze UV-mediated quercetin breakdown and is stable to UV 
radiation. The ability of quercetin to spare ketoprofen from UV radiation-induced 
decomposition may indicate an important role for quercetin in addition to its potential as 
a topical photoprotectant.  
Keywords 
quercetin; ketoprofen; oxybenzone; photosensitization; sunscreen. 
Classification codes 
82.50.Hp, 82.30.Lp, 82.80.Bg 
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6.2. Introduction 
 
     The non-steroidal anti-inflammatory drug ketoprofen (Figure 6.1) is commonly used 
in the treatment of musculoskeletal and joint disorders, ankylosing spondylitits, 
osteoarthritis and rheumatoid arthritis which may be applied orally, rectally, 
intramuscularly or intravenously as the sodium salt [1].  In addition, ketoprofen can be 
used topically as a 2.5% topical gel for local pain relief [1].  Ketoprofen however, is 
known to cause photosensitization resulting in lipid peroxidation, DNA damage and 
photoallergic contact dermatitis [1]. Photosensitization in the skin is a process whereby 
light, most often ultraviolet (UV) radiation, is absorbed by an endogenous or exogenous 
chromophore, resulting in damage to the surrounding tissue [2].  This process often 
proceeds through the generation of reactive oxygen species (ROS) where the excited 
chromophore passes the excitation energy to oxygen by a type II photoreaction [3].  
Alternatively, the excited state chromophore may pass the excitation energy to another 
biomolecule or undergo photoinduced changes itself in a type I photoreaction [3].   
O
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Quercetin                                                           Benzophenone
Ketoprofen                                                          Oxybenzone
OH
OCH3
 
Figure 6.1 - Structures of quercetin, benzophenone, ketoprofen and oxybenzone. 
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The photosensitization process has a number of deleterious effects in the skin 
including lipid peroxidation [4,5], induction of inflammatory cytokines [6], alteration of 
cell signalling processes [7-10], photoaging [11], immunosuppression [11, 12], DNA 
damage [13] and necrosis [11]. In addition to ketoprofen, a number of pharmaceutical 
and natural health products can also act as photosensitizers.  These include, but are not 
limited to, anti-inflammatory drugs such as naproxen, Central nervous system drugs such 
as proxibarbital, cardiovascular drugs such as digitoxin, and vitamins such as retinol 
[254].  Human skin also contains a number of endogenous photosensitizers which may 
contribute to photosensitization including bilirubin [10], urocanic acid, FMN, FAD [15], 
NADH, tryptophan, riboflavin [8], quinones [10], advanced glycation end-products 
formed on intra- and extra-cellular proteins [16, 17], unmodified extra-cellular proteins 
[18,19] and DNA [20].  
Ketoprofen likely causes photosensitization through the generation of reactive 
oxygen species and other radicals.  UV radiation exposure of ketoprofen has been shown 
to produce ROS including superoxide radical, hydroxyl radical and singlet oxygen [21].  
Ketoprofen exposed to UV radiation also produces radical species which have not been 
identified, although a ketoprofen carboxylic acid radical which undergoes 
decarboxylation to form a 3-(benzophenyl) ethane radical has been proposed [21].  A 
variety of radical scavengers, notably the plant polyphenol quercetin, have been shown to 
prevent the photodecomposition of ketoprofen and production of ROS [22]. 
Quercetin (Figure 1) is currently under investigation for use as a topically applied 
sunscreen and has proven to be effective in preventing UV radiation-induced lipid 
peroxidation [23] as well as UV radiation-induced production of biomarkers of UVA 
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(matrix metalloprotease-1) and UVB (tumor necrosis factor-) radiation in vitro 
(Fahlman and Krol, manuscript in preparation, see Chapter 6).  Quercetin is relatively 
stable to UV radiation in vitro as UV irradiation of quercetin results in the slow formation 
of three photoproducts [24].  The UV radiation-mediated decomposition of quercetin is 
however greatly accelerated by addition of the triplet state sensitizer benzophenone 
(Figure 1).  The aryl ketone portion of benzophenone is critical to its ability to act as a 
triplet sensitizer [25] and ketoprofen shares this structural feature (Figure 6.1).  The 
previous study which identified that quercetin could spare UV radiation-induced 
ketoprofen decomposition did not indicate the fate of quercetin after the UV exposure 
[22], and we hypothesize that ketoprofen might act as a UV sensitizer for quercetin in a 
manner similar to benzophenone.  In addition, the sunscreen ingredient oxybenzone 
(Figure 1) shares the same aryl ketone structural feature.  There is one report suggesting 
oxybenzone is unstable to UV radiation [26], although other studies have found that 
oxybenzone appears to be stable to UV radiation [27, 28].  In our studies we saw no 
significant loss of benzophenone when used as a triplet sensitizer [24], so it is possible 
that oxybenzone stability to UV radiation may not exclude triplet sensitization. 
There are two major objectives of this study, the first is to determine if the 
products derived from UV radiation of quercetin in the presence of benzophenone are 
also observed in a quercetin-ketoprofen irradiation. This would infer an excited state 
energy transfer protective mechanism for quercetin that may be a unique photoprotective 
property. The second objective is to determine whether oxybenzone can act as a UV 
sensitizer for quercetin decomposition and if quercetin spares any oxybenzone 
decomposition. 
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6.3 Materials and Methods 
6.3.1 Materials 
    Quercetin, ketoprofen and oxybenzone were purchased from Sigma (St. Louis, MO). 
All solvents were HPLC grade. Water was purified using a Millipore Super Q water 
system with one carbon cartridge followed by two ion exchange cartridges (Bedford, 
MA).  
2 FS20T12/UVB lamps (National Biological Corp., Beachwood, OH) filtered to remove 
UVC with an intensity of 1300 μW•cm-2 at 310 nm as measured with a UVP UVX-31 
sensor or 2 F20T12/BL/HO UVA lamps (National Biological Corp., Beachwood, OH) 
filtered to remove UVC with an intensity of 740 μW•cm-2 at 365 nm as measured with a 
UVP UVX-36 sensor were used for irradiation. 
6.3.2 High Performance Liquid Chromatography - Photodiode Array (HPLC-PDA) 
     HPLC-PDA analysis was carried out at room temperature on a Waters 600 system 
using a Waters 2996 photodiode array detector set at 365 nm.  Aliquots of 50 μL were 
injected onto a 250 x 4.6 mm Allsphere ODS-2 column, 5 μm particle size (Alltech, 
Calgary AB).  Data was processed using Empower software (Waters, Milford MA). 
Elution was carried out in gradient mode using two components: A = 0.1% formic acid in 
water, B = 0.1% formic acid in methanol.  For quercetin and ketoprofen analysis the 
gradient was as follows: 0 to 10 min, linear gradient from 90% A to 40% A; 10 to 25 
min, isocratic 40% A;  25 to 28 min, linear gradient from 40% A to 90% A; 28 to 30 min, 
isocratic 90% A.  For oxybenzone analysis the mobile phase was the same and the 
gradient was 20 min, linear gradient from 90% A to 40% A; 20 to 65 min, isocratic 40% 
A;  65 to 68 min, linear gradient from 40% A to 90% A; 68 to 70 min, isocratic 90% A.  
Flow rate was 1.2 mL/min.   
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6.3.3 UV Irradiation 
     For photostability analysis of pure compounds 25mL of 50µM of quercetin, 
ketoprofen or 250µM oxybenzone in methanol were placed in open 30mL culture dishes 
and exposed to UVA (740 μW•cm-2 at 365 nm) or UVB (1300 μW•cm-2 at 310 nm) for 2 
hours.  Solvent volume was monitored every 15 min and methanol was added to maintain 
a volume of 25mL.  
For photosensitization studies, 14 x 5mL samples of 50µM quercetin and 250µM  
benzophenone in methanol were placed in open 10mL culture dishes and exposed to  
UVA (740 μW•cm-2 at 365 nm) or UVB (1300 μW•cm-2 at 310 nm) for  2 hours.  
Samples were collected every 2.5 minutes for the first 15 minutes and then every 15 
minutes until the end of the exposure time (120 minutes).  To collect time points, one 
10mL culture dish was removed from under the lamp, and the contents volume corrected 
to 5mL to compensate for loss due to evaporation.  150µL of the volume corrected 
sample was taken for analysis by HPLC-PDA.         
6.3.4 Photoproduct Identification 
     Photoproducts were identified by retention time and UV spectra comparison to 
previously identified HPLC-PDA peaks [24]. (see Chapter 5) 
6.3.5 Statistical Analysis 
     Statistical analysis was carried out using a Student’s t-test performed with Microsoft 
Excel. 
6.4. Results and Discussion 
6.4.1 Photostability of Quercetin 
     UVA and UVB exposure of 50µM quercetin in methanol has previously been shown 
to result in less than 20% loss of starting material in 11 hours leading to low yields of 
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three photoproducts [24].  These photoproducts have been identified as 2,4,6-
trihydroxybenzaldehyde, quercetin depside and hydroxytyrosol.  The complete 
conversion of quercetin to the three photoproducts however can be accomplished in 1 h 
when the irradiation is carried out in the presence of 250 µM benzophenone, a triplet 
sensitizer [24] (see Chapter 4).  Benzophenone itself is however stable under our 
conditions as we saw no decrease in benzophenone levels after all of the quercetin had 
undergone conversion to photoproducts (data not shown). 
     It is important to note that the total UV exposures used in these experiments are based 
on those from our previous study which are the doses required to attain complete 
conversion of quercetin to photoproducts [24]. While the UVA dose of  293 kJ/m
2
 is 
environmentally relevant [29], the total UVB dose of  516 kJ/m
2
 used is much greater 
than a normal environmental dose of UVB [30, 31].   
6.4.2 Photostability of Ketoprofen 
      Our precise experimental setup differs from that of Nakajima [22], however UVA and 
UVB exposure of ketoprofen dissolved in methanol using our in vitro system resulted in 
complete loss of ketoprofen in two hours, which corresponds to the previously published 
results [21, 22] (Figure 6.2).  As indicated earlier for quercetin, the UV doses used in 
these studies are required for complete photodecomposition of ketoprofen and at least in 
the case of the UVB dose, exceeds that expected for an environmentally relevant level of 
exposure [24].  
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Figure 6.2 - Photostabilityof ketoprofen in methanol.  50µM ketoprofen in methanol 
was exposed to (a) no UVR, (b) UVA (740 μW•cm-2 at 365 nm) or (c) UVB (1300                 
μW•cm-2 at 310 nm) in uncovered 30mL culture dishes for 2 hours.  
Chromatograms were monitored at 302nm. 
 
     The original report on UV radiation-induced ketoprofen decomposition observed 
several decomposition products that eluted after the parent [22]. Under our HPLC 
conditions we were unable to observe any ketoprofen decomposition products.  Our 
HPLC conditions were optimized for separation of the quercetin photoproducts and thus 
differed substantially from those used in the original report.  The original ketoprofen 
study [22] utilized isocratic HPLC conditions which had a higher organic solvent content 
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than our gradient conditions, such that any ketoprofen decomposition products may have 
been obscured by the methanol wash conditions at the end of our gradient.  
     Exposure of 250µM ketoprofen to UVB (1300μW•cm-2 at 310 nm) for 1 h in the 
presence of 50µM quercetin resulted in no loss of ketoprofen, but partial loss of quercetin 
and the formation of the three quercetin photoproducts identified previously [24] (See 
Chapter 5) (Figure 6.3B).  After 2 h of UVB exposure, all of the quercetin had undergone 
decomposition while only a minor loss of ketoprofen (<10%) was observed (Figure 
6.3C).  Similar results were seen for UVA (data not shown). 
     A time course study of the UV radiation-induced loss of quercetin and ketoprofen and 
the formation of quercetin photoproducts using both UVA and UVB radiation was 
performed (Figure 6.4).  Figure 6.4 demonstrates that noticeable quercetin loss occurs 
within 2.5 min with concurrent formation of the three photoproducts for both UVA and 
UVB.  Loss of ketoprofen however is minimal until all of the quercetin has been lost 
(Figure 6.4).   
     However, once all of the quercetin had been depleted, loss of ketoprofen occurred in 
both UVA and UVB exposed samples, with loss in the UVB sample occurring more 
rapidly (Figure 6.4).  The results for UVA and UVB are similar to our previous results for 
UV radiation-induced quercetin decomposition in the presence of benzophenone, in 
which loss of quercetin occurs more rapidly under the UVB conditions [24].  Ketoprofen 
has been reported to form a triplet biradical upon UV irradiation [32], and this biradical 
may behave in a similar manner to the triplet sensitizer benzophenone.  A triplet 
sensitization process would be in line with our and other observations for quercetin-
mediated sparing of the UV radiation-induced decomposition of ketoprofen [22].   
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Figure 6.3 - Photostabilization of ketoprofen by quercetin in methanol.  (a) 250µM 
ketoprofen in methanol in the presence of 50µM quercetin was exposed to UVB 
(1300μW•cm-2 at 310 nm) in uncovered 10mL culture dishes for (A) 0 hours (B) 1 
hour or (C) 2 hours.  Chromatograms were monitored at 302nm. K = Ketoprofen, Q 
= quercetin, 1 = 2,4,6-trihydroxybenzaldehyde, 2 = Quercetin depside, 3 = 
Hydroxytyrosol. 
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Figure 6.4 - Time course for UV radiation-induced decomposition of quercetin (50 
μM in methanol) and ketoprofen and formation of quercetin-derived decomposition 
products, in the presence of ketoprofen (250 μM) (A) UVB radiation (1300 μW•cm-2, 
310 nm) for 2h, (B) UVA radiation (740 μW•cm-2, 365 nm) for 2 h. Individual time 
points are the peak areas from HPLC chromatograms at 302 nm, of the volume 
corrected reaction mixture. Error bars represent standard deviation from the mean 
of three replicates.  ♦ = Product 1, ■ = Product 2, ▲= Product 3, ●= Quercetin, ○ = 
Ketoprofen 
Exposure 
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6.4.3 Photostability of Oxybenzone 
UVB exposure of 250µM oxybenzone in methanol for two hours in open culture dishes 
resulted in no loss of starting material (Figure 6.5A).  Similar results were observed when 
UVA radiation was used in place of UVB (data not shown).  When 50µM quercetin was 
exposed to UVB in the presence of 250µM oxybenzone, no increase in the rate of 
formation of quercetin photoproducts was observed compared to quercetin alone (Figure 
6.5B).  The photostability of oxybenzone in our system, combined with the absence of an 
increase in quercetin photoproducts as observed when quercetin was irradiated in the 
presence of ketoprofen or benzophenone, indicates that oxybenzone is not acting as a 
photosensitizer.  Our results are consistent with previous reports suggesting that 
oxybenzone is stable to UV radiation [33, 34].  It has been suggested that this stability is 
due to an intramolecular hydrogen bond between the carbonyl and the 2-hydroxyl group 
of oxybenzone that leads to a fast, radiationless decay via tautomerization [35], thus 
avoiding a triplet state.  This hypothesis is in agreement with our results as neither 
ketoprofen nor benzophenone possess the required 2-hydroxyl group (Figure 6.1). 
In conclusion we have determined that ketoprofen can increase the UV radiation-
mediated decomposition of quercetin producing the same photoproducts as observed 
when benzophenone is used, and we suggest that ketoprofen acts as a triplet sensitizer in 
a similar manner as benzophenone.  Our results also support previous observations that 
quercetin can spare UV radiation-induced ketoprofen breakdown [1, 22].  As a result of 
this specific mechanistic interaction between ketoprofen and quercetin, these results 
suggest a potential photoprotective property of quercetin for the control of  
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Figure 6.5 - Photostability of oxybenzone and photosensitization by oxybenzone in                 
methanol.  250µM oxybenzone in methanol was exposed to UVB  (1300μW•cm-2 at 
310 nm) in uncovered 30mL culture dishes in the (A) presence or (B) the absence of 
50µM quercetin for 2 hours.  Chromatograms were monitored at 302nm. O = 
oxybenzone, Q = quercetin. 
ketoprofen photosensitivity.  Whether quercetin can minimize UV radiation-induced 
ketoprofen skin sensitivity in vivo remains to be determined.   
We also confirmed that oxybenzone is stable to UV radiation and does not act as a 
triplet sensitizer with the result that oxybenzone does not catalyze the UV radiation-
mediated decomposition of quercetin. It is interesting however to note a study in which 
oxybenzone was applied topically to artificial skin equivalents and the production of UV 
radiation-induced ROS was determined [34].  That study showed that oxybenzone was 
initially effective at decreasing UV radiation-induced ROS formation, however upon 
absorption into the epidermal layer, oxybenzone resulted in an increase in ROS 
formation.  The authors speculate that this may be due to triplet sensitization by 
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oxybenzone as the result of the highly lipophilic environment in the cell.  Whether 
quercetin could spare this oxybenzone-mediated ROS formation is unknown, but is an 
interesting hypothesis that warrants further investigation. 
6.5. Abbreviations 
Reactive oxygen species: ROS; High Performance Liquid Chromatography - Photodiode 
Array: HPLC-PDA; Ultraviolet: UV. 
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7.1 Abstract 
     Exposure of skin to ultraviolet light has been shown to have a number of deleterious 
effects including photo-aging, photo-immunosuppression and photo-induced DNA 
damage which can lead to the development of skin cancer.  The plant polyphenol 
quercetin is currently under investigation for potential use as a topically applied 
sunscreen affording protection from these negative effects.  In this paper we present an 
assessment of quercetin to prevent induction of the photo-damage biomarkers matrix 
metalloprotease 1 (MMP-1) and tumor necrosis factor α (TNF-α) in HaCaT cell cultures 
and EpiDerm skin mimics. 
     In HaCaT cell cultures dosed with quercetin in media 24 hrs prior to UVA or UVB 
exposure, a concentration of 100µM was found to significantly decrease secretion of 
MMP-1 in response to both UVA and UVB while no change was seen in TNF-α secretion 
at any of the  quercetin concentrations tested.  In EpiDerm samples treated topically with 
quercetin immediately prior to UVA or UVB exposure, a concentration of 100µM 
quercetin significantly decreased UVA induced MMP-1 secretion, but 200µM quercetin 
was required to significantly reduce UVB induced MMP-1 secretion.  TNF-α sectretion 
in EpiDerm samples was significantly reduced at 100µM quercetin for both UVA and 
UVB radiation.  In addition, topically applied quercetin was found to be photo-stable 
over the duration of the experiment.  
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7.2. Introduction 
     Ultraviolet radiation (UVR), defined as electromagnetic radiation in the range of 
100nm to 400nm, accounts for roughly 10% of the solar radiation that reaches the earth 
[1].  Of this radiation, the ultraviolet C (UVC) portion (<280nm) and 90% to 99% of the 
ultraviolet B (UVB) (280nm-315nm) is filtered by atmospheric ozone, leaving ultraviolet 
A (UVA) (315nm-400nm) as the major component of ultraviolet radiation to reach the 
earth's surface [1]. 
     The ultraviolet radiation that reaches the  earth's surface has a number of effects on 
mammalian systems.  Positive effects of UVR include regulation of circadian rhythm and 
of the conversion of 7-dehydrocholesterol to pre-vitamin D3, a precursor of vitamin D, 
which has a wide range of beneficial effects as reviewed by Goltzman [2] and Dixon et. 
al. [3].     Exposure to ultraviolet radiation also has a number of negative biological 
effects including lipid peroxidation leading to cell dysfunction or necrosis [4,5] 
destruction of skin collagen leading to photoaging [6], immunosuppression [7], and DNA 
damage leading to skin cancer, through either oxidative [8] or direct photochemical 
processes [9,10].   
     UVR induced photoaging is primarily associated with the UVA wavelengths and is 
characterized by increased wrinkle formation relative to unexposed skin, a loss of skin 
recoil capacity and an increase in skin fragility [11-13].  Histologically, the most 
prominent feature of photoaged skin is solar elastosis, characterized by degradation of 
collagen and accumulation of abnormal elastin [13,14].  UVA, and to a lesser extent 
UVB radiation, causes photoaging through induction of matrix metalloprotease-1 (MMP-
1) which is responsible for the breakdown of collagen [11,15-19].        
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     The molecular pathway leading from UVR exposure to induction of the matrix-
metalloproteases and photoaging is under investigation although it remains incomplete. It 
is well known that both UVA and UVB radiation can induce the formation of reactive 
oxygen species (ROS) in the skin [4,20] and there is good evidence that it is these ROS 
that initiate the photoaging process.  First, the level of H2O2, an inducer of MMP-1 [21], 
has been found to be elevated in photoaged skin relative to naturally aged skin, perhaps 
accounting for the differences in MMP activities [15].  Secondly, it has been shown that 
dark reaction produced 
1
O2, which can be converted to form H2O2, induces MMP-1 
mRNA in the same dose dependant manner as UVA in cultured fibroblasts [21].  In 
addition, exposure of fibroblasts to UVA resulting in MMP-1 upregulation has been 
shown to be enhanced by the addition of D2O, which increases the lifetime of 
1
O2 [22], 
and that addition of sodium azide, a quencher of 
1
O2, dramatically decreases the 
expression of MMP-1, implicating 
1
O2 in the process [23].  Taken together, these facts 
may show that the formation of ROS is the first step in photoaging.   
     The enzymatic pathway connecting ROS to photoaging has been filled in by a number 
of groups and appears to mediated through several interleukins.  It has been determined 
by Wlaschek, et. al. that fibroblasts exposed to UVA show an upregulation in IL-6 
mRNA and protein and that inhibition of the translation of IL-6 prevents MMP-1 
upregulation, showing that IL-6 is necessary for increases in MMP-1 activity [12].  This 
same group later showed that following UVA exposure, there is an initial increase in the 
release of existing IL-1 which triggers the de novo synthesis of IL-6 which leads to 
MMP-1 induction and IL-1 which perpetuates the UV response [24].   
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     Exposure to ultraviolet radiation, particularly UVB, has also been associated with 
immunosuppression, both local and systemic [6,7].  This immunosuppression is believed 
to reduce the risk of harmful, excessive inflammation in the skin following UVR 
exposure [6] and has been found to result from both acute [7] and chronic [25] exposure 
to UVR.   UVB induced immunosuppression occurs via down regulation of T-cell 
mediated immunity through the induction of immunomodulating cytokines [6,26].  UVB 
radiation has been shown to induce IL-10 [27,28], IL-4[28], IL-6 [29] and TNF-α [28].  
     The various interleukins induced by UVB radiation appear to have different functions 
in the immunosuppressive effect.  When IL-6 knockout mice are exposed to UVB, the 
loss of contact hypersensitivity seen in wild type mice as well as the increase in IL-6 and 
IL-10 levels in the blood were absent [29].  However, when the knockout mice were 
injected with IL-6, the IL-10 levels increased and immunosuppression was observed, 
supporting a role for UVB mediated induction of IL-6 which in turn induces IL-10 
leading to immunosuppression [29].  This same study indicated that the cells responsible 
for IL-6 production appeared to be Langerhan’s cells [29].   
     The initial skin chromophore involved in immunosuppression has been shown to be 
DNA, and UVR absorption by DNA resulting in the formation of thymine dimers is also 
the initiating step in photo-carcinogenesis [9,30].   UVB radiation is directly absorbed by 
pyrimidine residues, especially thymine.  These excited residues then react with adjacent 
pyrimidine residues forming pyrimidine dimers [31,32].  These dimers can be formed 
between two adjacent thymines (T<>), two adjacent cytosines (C<>C) or between 
adjacent thymine-cytosine pairs (T<>C).  The pyrimidine dimers can take a number of 
forms including 6-4 dimers and their Dewer isomers or most commonly cyclo-pyrimidine 
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dimers (CPD’s) which are formed by [2+2] cycloaddition between the C5-C6 double 
bonds of adjacent pyrimidines [31,33].  The relative frequency of occurence of these 
dimers in sun exposed skin is T<>T > T(6-4)C > T<>C > T(6-4)T [31]. 
     Yarosh, et. al. [34] demonstrated that in HaCaT cells UVB radiation induces the 
immunosuppressive cytokine TNF-α, and that this same cytokine was induced when 
DNA was damaged using HindIII.  The same group also showed that increased repair of 
CPDs by addition of T4 endonuclease V, which is specific for UVR induced DNA 
damage, resulted in a decrease in immunosuppression [34].   Similar results have shown 
that in in vivo human experiments, T4 endonuclease V given after SSR exposure 
prevented immunosuppression [35]. 
     If photo-induced dimers are not repaired prior to replication, they can result in C to T 
and CC to TT transversions.  If these mutations occur in a protein coding region, 
particularly in the coding region for a regulatory protein such as p53, they can lead to the 
formation of carcinomas [6,36].  These photoinduced skin carcinomas fall into two broad 
categories, melanomas and non-melanomic skin carcinomas (NMSC) [8].  Melanomas, 
which are associated with a small number of intense UVR exposures (sunburns) occur 
when the UVR induced DNA damage takes place in melanocytes and account for roughly 
4% of skin carcinomas [37].  Although relatively rare, melanomas are aggressive and 
likely to metastasise, resulting in a high mortality rate [37].  The majority of skin 
carcinomas are NMSC which are sub-divided into squamous cell carcinomas (SCC) and 
basal cell carcinomas (BCC) [36].  Both types of NMSC are associated with cumulative, 
long-term UVR exposure and are caused by mutations in the keratinocytes [6].  NMSC 
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are generally less likely to metastasise than melanomas and generally result in 
disfigurement rather than mortality [37,38]. 
     Due to the negative effects associated with overexposure to solar UVR, a large 
number of topically applied sunscreens are available on the market and the development 
of new sunscreens is an active area of research.  One of the approaches being used in the 
development of new sunscreen products is the incorporation of natural products produced 
by plants for the purpose of UVR protection [39-41]. 
     One phytochemical which is believed to have photoprotective properties in plants is 
the flavanoid quercetin (3, 3', 4', 5, 7-pentahydroxyflavone, Figure 7.1)).  Quercetin has 
absorption bands in the UV range [42] and both the parent as well as various quercetin 
glycosides have been shown to be upregulated in response to UVR exposure in a number 
of plant species including Brassica napus [43], Petunia axillaris [44], Malus domestica 
[45].  Use of quercetin as a photoprotectant has proven effective in both human 
fibroblasts which showed a decrease in photoinduced MMP-1 production following 
quercetin treatment [46], and in mice where dietary  intake of quercetin by mice has been 
shown to decrease UVR induced immunosuppression [47,48]. 
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Figure 7.1 - Structure of quercetin (3, 3’, 4’, 5, 7-pentahydroxyflavone) 
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     In addition to UVR absorbance, quercetin is also a strong antioxidant with each 
molecule capable of scavenging four radical species [49].  The potential for contribution 
from both an antioxidant and a UVR absorptive pathway has left the mechanism of 
quercetin photoprotection in mammalian systems unclear. 
     We hypothesize that quercetin can reduce UVR induced oxidative damage, including 
photoaging, and direct DNA damage in skin in vitro.  To study this question we used 
HaCaT cell cultures and artificial skin mimics and determined the ability of quercetin to 
prevent UVR induced damage using MMP-1 and TNF-α as markers of UVR induced 
damage.  Our results showed that quercetin added to cell culture media or applied 
topically to artificial skin mimics is effective in preventing the production of MMP-1, a 
marker for photoaging, and TNF-α, a marker for immunosuppression and a secondary 
marker for UVR induced DNA damage, specifically CPD formation.  These results, 
together with our previous findings showing good photostability [50] and effective 
protection from photoinduced lipid peroxidation [49] indicate that quercetin may prove 
an effective component of a topically applied sunscreen. In this study, the endpoints 
studied were primarily photoaging and immunosuppression/direct DNA damage. 
7.3. Methods and Materials 
7.3.1 Chemicals 
     Quercetin was purchased from Sigma (St. Louis, MO). All solvents were HPLC grade. 
Water was purified using a Millipore Super Q water system with one carbon cartridge 
followed by two ion exchange cartridges (Bedford, MA).  
     2 FS20T12/UVB lamps (National Biological Corp., Beachwood, OH) filtered to 
remove UVC with an intensity of 1300 μW•cm-2 at 310 nm as measured with a UVP 
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UVX-31 sensor or 2 F20T12/BL/HO UVA lamps (National Biological Corp., 
Beachwood, OH) filtered to remove UVC with an intensity of 740 μW•cm-2 at 365 nm as 
measured with a UVP UVX-36 sensor were used for irradiation. 
     HaCaT cells were obtained from Cell Lines Service (Eppelheim, Germany) and 
cultured with Dulbecco’s Modified Eagle Medium (DMEM) containing 10% foetal 
bovine serum (FBS) purchased from Invitrogen (Burlington, ON).  EpiDerm™ skin 
mimics and media were purchased from MatTek Corporation, Ashland, MA. 
     Quantikine
®
 Human pro-MMP-1 ELISA kits and Quantikine
®
 Human TNF-
α/TNFSF1A ELISA kits were purchased from Cedarlane Laboratories Ltd., Burlington, 
ON and read using a Synergy™ HT Multi-Detection Microplate Reader (BioTek 
Instruments Inc., Winooski, VT). 
7.3.2 Cell Cultures 
7.3.2.1 HaCaT Cells 
     HaCaT cell cultures were grown as per the supplier’s instructions.  Briefly, 4x105 cells 
were suspended in 15 mL of Dulbecco’s Modified Eagle Medium (DMEM) containing 
10% foetal bovine serum (FBS), plated onto T-75 culture flasks and incubated at 37ºC 
with 5% CO2.  When cells reached 90% confluency they were treated with 0.05% EDTA 
/ 0.1% trypsin in phosphate buffered saline (PBS) to detach and seeded onto 6 well plates 
at a density of 5x10
3
 cells/cm
2
.  The six well plates were incubated in DMEM containing 
10% FBS at 37ºC with 5% CO2 until 90% confluency was reached prior to treatment.   
7.2.2.2 EpiDerm Skin Mimics 
     EpiDerm artificial skin mimics were purchased from MatTek (Ashland, MA) and used 
as per the supplier’s instructions.  Briefly, upon receipt of the samples, individual skin 
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mimics were placed in each well of a 6-well culture plate along with 1mL of maintenance 
media and incubated at 37°C with 5% CO2 overnight.  Following incubation, the 
maintenance media was replaced with assay media for UVR exposure. 
7.3.3 Quercetin Treatment 
7.3.3.1 HaCaT Cell Cultures 
     For dosing with quercetin, each well containing HaCaT cells at 90% confluency was 
washed with PBS, and 2mL DMEM with 10% FBS was added.  To the media was added 
0.5µL, 1.0µL, 2.0µL or 4.0µL of 65mM quercetin in DMSO to obtain concentrations of 
25µM, 50µM, 100µM and 200µM respectively.  Quercetin control contained 4µL DMSO 
and vehicle control had neither DMSO nor quercetin added to the media.  Following 
dosing, cells were returned to the incubator at 37°C with 5% CO2 for 24 hours.  All doses 
were done in triplicate.  
7.3.3.2 EpiDerm Skin Mimics 
     EpiDerm skin mimics were treated topically with quercetin in acetone immediately 
prior to UVR exposure.  The amount of quercetin used was calculated to be the same 
mass of quercetin delivered on to the skin per cm
2
 as was delivered to the HaCaT cells of 
concentrations of 100µM and 200µM.  Skin mimics were treated with 50µL and 100µL 
of 26µM quercetin in acetone to achieve doses equivalent to 100µM and 200µM.  
Following application of the quercetin in acetone, samples were left for 10min to allow 
acetone to evaporate leaving a thin layer of quercetin on the skin prior to UVR exposure.  
All doses were done in triplicate. 
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7.3.4 UVR Exposure 
7.3.4.1 HaCaT Cell Cultures 
     For UVR exposure cells were removed from the incubator after 24 hours and the 
media removed and replaced with PBS.  Samples were then placed under lamps without 
covers.  For UVB exposure, cells were placed 20cm from 2 FS20T12/UVB lamps 
(National Biological Corp., Beachwood, OH) which resulted in an intensity of 
500µW/cm
2
 at 310nm and the cells were exposed for 30 min for a total dose of 9000J/m
2
.  
For UVA exposure, cells were placed 4cm from 2 F20T12/BL/HO UVA lamps (National 
Biological Corp., Beachwood, OH) which resulted in an intensity of 700µW/cm
2
 at 
365nm and the cells were exposed for 240 min for a total dose of 100kJ/m
2
.  For dark 
samples, plates were wrapped in aluminum foil and placed under 2 F20T12/BL/HO UVA 
lamps (National Biological Corp., Beachwood, OH) for 240 min to account for heating 
effects.  Output of all lamps was filtered to remove UVC radiation.  Following exposure, 
PBS was removed and replaced with 2mL fresh DMEM with 10% FBS and samples were 
returned to the incubator at 37°C with 5% CO2. Cell cultures were removed from the 
incubator 24 hours after exposure and media collected and placed in a -80°C freezer for 
later analysis. 
7.3.4.2 EpiDerm Skin Mimics 
     For UVR exposure skin mimics once the acetone vehicle had evaporated samples 
were placed under lamps without covers.  For UVB exposure, cells were placed 20cm 
from 2 FS20T12/UVB lamps (National Biological Corp., Beachwood, OH) which 
resulted in an intensity of 500µW/cm
2
 at 310nm and the samples were exposed for 30 
min for a total dose of 9000J/m
2
.  For UVA exposure, cells were placed 4cm from 2 
F20T12/BL/HO UVA lamps (National Biological Corp., Beachwood, OH) which 
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resulted in an intensity of 700µW/cm
2
 at 365nm and the samples were exposed for 240 
min for a total dose of 100kJ/m
2
.  For dark samples, plates were wrapped in aluminum 
foil and placed under 2 F20T12/BL/HO UVA lamps (National Biological Corp., 
Beachwood, OH) for 240 min to account for heating effects.  Output of all lamps was 
filtered to remove UVC radiation.  Following exposure samples were returned to the 
incubator at 37°C with 5% CO2. Cell cultures were removed from the incubator 24 hours 
after exposure and media collected and placed in a -80°C freezer for later analysis. 
7.3.5 ELISA Analysis 
7.3.5.1 pro-MMP-1 
     Extracellular pro-MMP-1 produced in response to UVR in the presence or absence of 
quercetin was measured using a Quantikine
®
 Human pro-MMP-1 ELISA kit (R&D 
Systems, Minneapolis, MN) following the manufacturer's directions.  Briefly, 100µL of 
culture media and 100µL of diluent solution were added to each well of a 96-well plate 
and shaken at room temperature for 2 hours.  The samples were aspirated, the plate was 
washed four times and 200µL of conjugate was added to each well and the plate shaken 
at room temperature for 2 hours.  Conjugate solution was aspirated, the plate was washed 
four times and 200µL substrate solution was added to each well followed by a 20 min 
incubation protected from light.  50µL of stop solution was then added to each well and 
the absorbance at 450nm and 570nm was recorded using a BioTek Instruments 
(Winooski, VT) plate reader.  An eight point calibration curve was prepared using 
standards provided by the supplier and the pro-MMP-1 concentration of each well was 
determined by interpolation.  
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7.3.5.2 TNF-α 
     Extracellular TNF-α  produced in response to UVR in the presence or absence of 
quercetin was measured using a Quantikine
®
 Human TNF-α/TNFSF1A ELISA kit (R&D 
Systems, Minneapolis, MN) following the manufacturer's directions.  Briefly, 50µL of 
culture media and 200µL of diluent solution were added to each well of a 96-well plate 
and incubated at room temperature for 2 hours.  The samples were aspirated, the plate 
was washed four times and 200µL of conjugate was added to each well and the plate 
incubated at room temperature for 1 hour.  Conjugate solution was aspirated, the plate 
was washed four times and 200µL substrate solution was added to each well followed by 
a 20 min incubation protected from light.  50µL of stop solution was then added to each 
well and the absorbance at 450nm and 570nm was recorded using a BioTek Instruments 
(Winooski, VT) plate reader.  An eight point calibration curve was prepared using 
standard provided by the supplier and the TNF-α concentration of each well was 
determined by interpolation. 
7.3.6 Quercetin Stability 
     The stability of quercetin which was topically applied to the EpiDerm tissues was also 
assessed.  Following UVA or UVB exposure 100µL of acetone was placed on the 
EpiDerm samples and allowed to re-dissolve the UVR exposed quercetin and 
photoporducts.  The acetone was then collected and analyzed by HPLC-PDA as 
described previously [50] (Chapter 5).   
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7.3.7 Statistics 
     Statistical analyses were performed using GraphPad Prism 5.0 (GrpahPad Software 
Inc., La Jolla, CA).  Data was analyzed by one-way ANOVA with a Bonferroni's 
Multiple Comparison Test.  The level of significance was set at P<0.05. 
7.4 Results 
     The ability of quercetin to prevent UVA and UVB induced production and/or release 
of MMP-1 and TNF-α was initially assessed in cultured keratinocyte mono-layers.  In 
these experiments the keratinocyte cultures were dosed with appropriate amounts of 
quercetin in the cell media 24 hours prior to exposure to UVA or UVB and the media was 
removed prior to exposure.  As a result, any photoprotective activities seen in this set of 
experiments would be due to quercetin that had been taken up by the cells during the 
dosing period.  As such, the quercetin could be acting in an antioxidant capacity [49,51], 
a photoabsorptive capacity [43,47,48], an enzyme modulating capacity [46] or any 
combination of these mechanisms.   
     As can be seen from Figure 7.2, pre-treatment of HaCaT cells with 100µM and 
200µM quercetin in media 24 hours prior to UVR exposure resulted in a significant 
decrease in the amount of MMP-1 released by the cells relative to both vehicle control 
(DMSO) and untreated cells.  This significant decrease in MMP-1 release is seen in both 
UVA and UVB exposed cells, though the decrease is more dramatic in the UVA exposed 
cells.  Pre-treatment of the HaCaT cells with 50µM quercetin 24 hours prior to UVR 
exposure shows a trend towards a decrease in MMP-1 release in both UVA and UVB 
exposed cells, but this decrease did not reach the level of significance due to high 
variability in the vehicle control and untreated samples.    
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     The effects of pre-treatment with quercetin on the production of TNF-α by HaCaT 
cells is presented in Figure 7.3.  In contrast to the results seen for MMP-1, pre-treatment 
of HaCaT cells did not result in a significant decrease in TNF-α production, even when 
doses up to 200µM quercetin were used. 
 
0 25 50 10
0
20
0
0
2
4
6
8
*
C
on
tro
l
*
*
*
*
*
*
* *#
#
#
#@
@
@
@
Quercetin Conc (M)
S
e
c
re
te
d
 M
M
P
-1
 (
n
g
/m
L
)
 
Figure 7.2 – Quercetin prevention of MMP-1 production by HaCaT cell cultures 
exposed to either 100kJ/m2 UVA, 900J/m2 UVB (in open culture dishes, UVC 
removed by filtration) or no UVR (dark) by ELISA.  Cell cultures were treated with 
quercetin in DMSO (<2% by volume) added to media 24 hours prior to exposure.  
For UVR exposure, media was replaced with phosphate buffered saline, following 
treatment saline was replaced with DMEM and cells were returned to the incubator.  
Media was collected for pro-MMP-1 analysis 24 hours later and stored at -80ºC 
until analysis. = UVA, = UVB Treatment, = Dark Control.  * = 
significantly different from dark control (P<0.05), # = significantly different from 
control (P<0.05), @ = significant different from 0µM (vehicle control) (P<0.05). 
       
     Following the preliminary study using cultured HaCaT cells, the effectiveness of 
quercetin as a photo-protectant was assessed using an EpiDerm
TM
 artificial skin mimic.  
In this case quercetin was applied topically to the stratum corneum of the skin mimics 
immediately prior to UVR exposure.  In contrast to the HaCaT cell study where quercetin 
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was able to fully incorporate into the cell allowing for possible effects on cell signalling 
and intracellular antioxidant activity, topical application relies primarily on photo-
absorptive processes and intercellular and cellular membrane antioxidant activity to 
provide photoprotection. 
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Figure 7.3 – Quercetin prevention of TNF-α production by HaCaT cell cultures 
exposed to either 100kJ/m2 UVA, 900J/m2 UVB (in open culture dishes, UVC 
removed by filtration) or no UVR (dark) by ELISA.  Cell cultures were treated with 
quercetin in DMSO (<2% by volume) added to media 24 hours prior to exposure.  
For UVR exposure, media was replaced with phosphate buffered saline, following 
treatment saline was replaced with DMEM and cells were returned to the incubator.  
Media was collected for TNF-α analysis 24 hours later and stored at -80ºC until 
analysis. = UVA, = UVB Treatment, = Dark Control.  * = significantly 
different from dark control (P<0.05) 
 
6.3.2. UVR exposed EpiDerm
TM
 
     The effect of topical quercetin treatment of EpiDerm
TM
 on MMP-1 excretion is 
presented in Figure 7.4.  As can be seen in this graph, both UVA and UVB exposed 
samples treated with the equivalent of either 100µM or 200µM quercetin resulted in a 
significant decrease in MMP-1 production compared to control.  In fact, for both UVA 
 129 
and UVB exposed EpiDerm
TM
 treated with 200µM quercetin, extracellular production of 
MMP-1 decreased to the level seen in non-UVR exposed skin mimics (dark control). 
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Figure 7.4 – Quercetin prevention of MMP-1 production by EpiDermTM skin mimics 
exposed to either 100kJ/m2 UVA, 900J/m2 UVB (in open culture dishes, UVC 
removed by filtration) or no UVR (dark) by ELISA.  Cell cultures were treated with 
quercetin in acetone, which was allowed to evaporate, immediately prior to UVR 
exposure leaving a thin film of quercetin.  Following treatment skin mimics were 
returned to the incubator.  Media was collected for MMP-1 analysis 24 hours later 
and stored at -80ºC until analysis. = UVA, = UVB Treatment, = Dark 
Control.  * = significantly different from dark control (P<0.05), # = significantly 
different from control (P<0.05). 
     
      Figure 7.5 shows the effects of topical quercetin treatment of the EpiDerm
TM
 skin 
mimics on the production of TNF-α.  For UVR treated EpiDermTM, TNF-α production 
shows a pattern similar to that seen for MMP-1 with significant decreases in both UVA 
and UVB-induced TNF-α production at 100µM and a complete loss of TNF-α production 
to dark control levels in those skin mimics treated with 200µM quercetin.  In fact, for the 
UVA exposed samples, reduction to dark control levels of TNF-α was seen at 100µM 
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quercetin treatment.  This is in contrast to the HaCaT cell experiments where quercetin 
had no effect on TNF-α production. 
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Figure 7.5 – Quercetin prevention of TNF-α production by EpiDermTM skin mimics 
exposed to either 100kJ/m2 UVA, 900J/m2 UVB (in open culture dishes, UVC 
removed by filtration) or no UVR (dark) by ELISA.  Cell cultures were treated with 
quercetin in acetone, which was allowed to evaporate, immediately prior to UVR 
exposure leaving a thin film of quercetin.  Following treatment skin mimics were 
returned to the incubator.  Media was collected for TNF-α analysis 24 hours later 
and stored at -80ºC until analysis. = UVA, = UVB Treatment, = Dark 
Control.  * = significantly different from dark control (P<0.05), # = significantly 
different from control (P<0.05). 
      Assessment of the photodegradation of quercetin applied topically to EpiDerm 
samples show that little loss observed as shown in Figure 7.6.  As can be seen, the major 
component of the recovered photoprotectant is the parent compound quercetin with only 
trace amounts of the decomposition product quercetin depside [50] present.  This stability 
of quercetin is in contrast to the decomposition of quercetin seen in DMEM [52], 
suggesting that the decomposition of quercetin observed was not due to UVR alone. 
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Figure 7.6 – HPLC analysis of quercetin exposed to UVA or UVB radiation on 
EpiDerm (A) UVA exposed quercetin (B) UVB exposed quercetin. 
 
7.5. Discussion 
     A number of studies have suggested that flavonoids such as quercetin may have 
photoprotective properties.  In an effort to develop a reliable model system to test topical 
photoprotectants, we decided to investigate the use of an artificial skin mimic as our 
model system. Two biomarkers of UVR induced damage were employed, MMP-1 
secretion which is a marker of ROS mediated damage and photoaging effects and TNF-α, 
a marker of photo-immunosuppression and direct photodamage to DNA.  We used this 
system to determine whether quercetin could provide some level of protection to skin 
from UVR.  The study presented here shows that in both HaCaT cell culture systems and 
artificial skin mimics quercetin can reduce UVR induced photodamaging effects.  Pilot 
studies carried out in cell culture systems determined that pre-treatment with quercetin 24 
 132 
hours prior to UVA or UVB exposure resulted in decreased secretion of MMP-1, but had 
no effect on secretion of TNF-α.  In contrast to this, topical treatment of artificial skin 
mimics with quercetin resulted in significant decreases in both MMP-1 and TNF-α 
excretion. 
     Two different routes of administration of quercetin were used in this study.  The cell 
culture systems were used in an effort to establish appropriate concentration ranges of 
quercetin to be used in the human skin mimic (EpiDerm
TM
) studies.  In the case of the 
HaCaT cell cultures, quercetin was dosed into the cell media 24 hours prior to UVA and 
UVB exposure.  This dosing protocol allows for absorption of quercetin into the cell prior 
to exposure to UVA or UVB radiation.   A recent study determined that quercetin could 
induce apoptosis in UVB treated HaCaT cells, however the study also observed that 
quercetin was unstable in DMEM and decomposed to unknown products, although the 
extent of uptake of intact quercetin or decomposition products into the HaCaT cells is 
unknown [52].  Based on the known decomposition of quercetin [53] and our own 
investigations [50], we predict that the major decomposition product in DMEM is likely 
the quercetin depside.  Interestingly, stabilization of quercetin in DMEM with ascorbic 
acid reduced the apoptotic effect [52].  The authors suggest that the apoptotic effect of 
quercetin may be affected by a combination of the parent compound, the decomposition 
products and ROS generated from redox cycling of the parent or breakdown products.    
We concur that the effects seen in our experiments using HaCaT cells may be mediated 
by absorbed quercetin, quercetin decomposition products, or both.  Since the level of 
uptake of quercetin or decomposition products into the HaCaT cells and the antioxidant 
properties of the quercetin decomposition products is unknown, it is conceivable that 
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quercetin, the decomposition products or both may be acting as antioxidants.  
Nevertheless, the results of our pilot study suggest that quercetin concentrations in the 
100 to 200 µM range can reduce UVR induced MMP-1 production in HaCaT cells, and 
that quercetin could be acting through a number of mechanisms including direct photo-
absorption, intercellular antioxidant activities and alteration of cell signalling pathways. 
     In contrast to the HaCaT cells, the EpiDerm
TM
 artificial skin mimics were treated 
topically with quercetin immediately prior to UVA and UVB exposure.  Due to the 
immediate exposure to UVR, the quercetin would not have been absorbed by the skin and 
as a result would only be available to act as a physical screen or as a surface / 
intracellular antioxidant. In addition, the instability of quercetin observed in the HaCaT 
cell system was not seen as little or no loss of quercetin was observed. (Figure 7.6)  
     The two different routes of quercetin administration used in this study and the 
differences in MMP-1 and TNF-α secretion seen as a result may give some insight into 
the mode of action of quercetin in each case.     
7.5.1  Effect of Quercetin on UVR Mediated MMP-1 Production 
     The quercetin-mediated concentration-dependent decrease in MMP-1 secretion seen in 
the EpiDerm
TM
 treated immediately prior to exposure could result from either inhibition 
of MMP-1 secretion via antioxidant activity or direct photo-absorption.  MMP-1 
induction by UVA and UVB radiation has been shown to be caused by the formation of 
ROS at the cell surface[4,20-22].  As a result, both the absorbed and surface quercetin 
would be able to prevent initiation of MMP-1 secretion by preventing the formation of 
ROS at the surface of the cell, as was seen in this study.  Our previous studies on UVR 
induced decomposition of quercetin [50] as well as other oxidation studies [53] suggest 
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that 
1
O2 may interact with quercetin and this scavenging of 
1
O2 may contribute to the 
quercetin-mediated reduction in MMP-1 production [23].   
     Quercetin may also act as a direct UVR screen, absorbing UVR and dissipating energy 
before ROS can be generated (note: quercetin was used at concentrations below those 
known to generate ROS in the presence of UVR).  This absorptive effect should be 
localized to the surface of the skin in the EpiDerm
TM
 samples.  However, the absorbance 
spectrum of quercetin has a λmax in the UVA region (365 nm, ε = 28,400 M
-1
cm
-1
) and a 
low extinction coefficient in the UVB region, so it seems unlikely that the 
photoprotective effect would be equally strong against both UVB and UVA radiation, as 
is seen in this study.  Our data for both the EpiDermTM and HaCaT systems suggest it is 
likely that the ability of quercetin to prevent MMP-1 secretion is largely an antioxidant 
effect in both systems.     
7.5.2  Effect of Quercetin on UVR Mediated TNF-α Production 
     Surprisingly, we observed a dose-dependent decrease in TNF-α secretion in the 
EpiDerm
TM
 study, a result that was not predicted by the HaCaT pilot study as no 
significant decrease was seen in the HaCaT cells.  There are several possibilities to 
explain this observation, if the quercetin decomposition products predominate in the 
HaCaT cells they may have no effect on TNF-α secretion or the mechanism by which 
quercetin prevents secretion of TNF-α in the EpiDermTM samples is not present in the 
HaCaT cells.  Since there is little time for absorption to occur following the topical 
treatment in the EpiDerm
TM
 samples, it is unlikely that quercetin is available to interfere 
with the signalling pathways activated following UVR exposure [28] leading to TNF-α 
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secretion.  However, this leaves the possibilities of antioxidant activity and photo-
absorption.  
     We anticipate that quercetin remains largely on or near the surface of the EpiDerm
TM
 
samples so that the antioxidant potential of quercetin is available mainly to the surface 
cells.  Conversely we anticipate that quercetin and/or the decomposition products, and 
therefore their antioxidant properties, are more widely distributed in the HaCaT cell 
experiments.  This lowered availability for antioxidant activity should result in a 
decreased level of protection in the skin mimics compared to the HaCaT cells.  However, 
we did not observe this, rather a decrease in TNF-α secretion was seen only in the 
EpiDerm
TM
 skin mimics. 
     TNF-α is known to be formed as a result of the formation of thymine dimers by a 
UVR-induced photo-reaction [34,35].  This is a direct photo-reaction caused by 
absorption of light by DNA, primarily thymine (λmax = 264 nm), and does not go through 
a ROS intermediate.  In fact, DNA damage caused by reaction with ROS results in the 
formation of DNA lesions distinct from thymine dimers which have not been shown to 
cause TNF-α production [34,35].  This causative relationship between thymine dimer 
formation and TNF-α production further supports the conclusion that in the case of the 
decreased TNF-α secretion seen in the EpiDermTM samples, direct UVR absorption is the 
major protective mechanism of quercetin.  A strong absorbance band of quercetin (λmax = 
256 nm, ε = 28,300 M-1cm-1) is near that of thymine, while the major decomposition 
products previously identified for quercetin show little absorbance in the UVC region, 
instead having absorbance maxima near 300 nm [50,53].  Thus, if the decomposition 
products predominate in the HaCaT cells, they would be anticipated to provide a weaker 
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absorptive effect than quercetin.   In addition, the topical treatment immediately prior 
UVA and UVB exposure should provide a greater level of protection than the pre-
exposure of the HaCaT cells as the cell media containing quercetin is removed from the 
cell cultures prior to UVR exposure. This leaves only that quercetin which has been 
absorbed by the cells and remaining near the cell surface available to offer 
photoprotection by light absorption.  A decrease in the effectiveness of the photo-
protection offered by quercetin would be expected in the pre-treated HaCaT cells as 
opposed to the topically treated EpiDerm
TM
 cells which is in agreement with our results. 
     Using the artificial skin mimic EpiDerm
TM
, we have demonstrated that topically 
applied quercetin decreases two markers of UVR-induced skin damage in a 
concentration-dependent manner.  These markers were selected to be indicators of UVR-
induced ROS (MMP-1) and direct UVR absorption by DNA (TNF-α). Use of HaCaT 
cells as a pilot study for the EpiDerm
TM
 experiments resulted in a quercetin-mediated 
decrease of MMP-1, but no effect on TNF-α, which we attribute to the instability of 
quercetin in cell media such as DMEM.  Our results are in agreement with quercetin 
providing a photoprotective effect both as an antioxidant and through absorption of UVR.  
Previous studies on the apoptotic properties of quercetin in UVR treated HaCaT cells 
suggested that stabilizing quercetin was not necessarily beneficial [52]. While we 
observed different markers of biological damage than Bowden’s group, our results agree 
with studies on topical quercetin formulations which suggest the importance of quercetin 
stability in the prevention of UVR-induced skin damage[54]. 
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8. Summary and Conclusions 
     The overall aim of this research project was to assess the utility of the natural product 
quercetin as a topically applied sunscreen and in order to accomplish this goal four 
specific targets were set. First, the ability of quercetin to prevent lipid peroxidation in a 
model lipid membrane system was quantified using both a chemical oxidant as well as 
UVA and UVB radiation to initiate oxidation.  Second, the photostability of quercetin 
was determined and the photodecomposition products were identified.  Third, the ability 
of quercetin to prevent pharmaceutical photosensitization by the drug ketoprofen was 
assessed by determining if quercetin could prevent photodecomposition of ketoprofen 
and if so what happened to quercetin during the process.  Fourth, the ability of quercetin 
to prevent the generation of MMP-1 and TNF-α, markers of photoaging and UVR 
induced DNA damage respectively was assessed in both HaCaT cell cultures and 
EpiDerm artificial skin mimics.   
     The following sections summarize the findings of this study and put these findings 
into the context of the project as a whole.   
8.1 - Determination of the anti-oxidant capacity of quercetin in a simulated 
membrane system 
     The measurement of quercetin’s antioxidant stoichiometry in DLPC lipid membranes 
showed that each molecule of quercetin is capable of scavenging four reactive radical 
species, making quercetin a highly effective antioxidant.  Since many of the negative 
effects of sunlight on skin are caused by the generation of ROS, this indicates that 
quercetin may be effective in preventing photo-oxidative skin damage.  Interestingly, the 
stoichiometry of quercetin was the same for oxidation initiated by UVB and for oxidation 
initiated by the chemical oxidant AAPH.  This indicates that quercetin’s ability to protect 
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the model membranes against UVB induced oxidation is due to its ability to scavenge 
radical species and not due to any direct absorption of UVB radiation.  Due to quercetin’s 
relatively weak absorbance in the UVB range, this result is not surprising, especially 
given quercetin’s strong anti-oxidant ability.  More surprising is that when lipid 
peroxidation was initiated by UVA radiation quercetin offered less protection, showing 
an anti-oxidant stoichiometry of only 2.  This result was unexpected since quercetin has 
an absorbance maximum in the UVA range at a wavelength of 365nm.  We speculate that 
the increased absorption of energy in the UVA range results in quercetin forming a high 
energy intermediate with decreased anti-oxidant capacity and possible pro-oxidant 
activity.  In spite of the decreased effectiveness of quercetin as an antioxidant against 
UVA, it still offers some degree of protection, scavenging two reactive radicals for each 
molecule of quercetin.  Taken together the data from the first set of experiments indicates 
that quercetin is an effective protectant of lipid membranes against UVB, and to a lesser 
extent UVA, induced peroxidation by acting as a potent radical scavenger.  Since many 
of the negative skin effects associated UVR exposure of skin are mediated through 
reactive species, the strong anti-oxidative activity of quercetin indicates good potential 
for use as a topical photoprotectant. 
8.2 - Determination of the photostability of quercetin and identification of 
quercetin’s photodecomposition products 
     The photostability of quercetin was determined in both methanol and a methanol-
water mixture and in the presence of both UVA and UVB radiation.  Quercetin was found 
to have good photostability with less than 20% loss of quercetin following 11 hours of 
exposure.  Since exposure to UVR at the intensities used in the experiment for a total of 
11 hours is highly unlikely if not impossible in a normal usage situation, the loss of 
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quercetin seen in our studies is not a large negative influence on its utility as a 
photoprotectant.  In fact, the rate of decomposition of quercetin was so slow that a 
photosensitizer, benzophenone, had to be added in order to generate sufficient product for 
identification.  However, the formation of decomposition products, even in small 
amounts, requires that the products be identified.  HPLC-PDA and HPLC-MS analysis 
demonstrated that the same three photoproducts were formed when either UVA or UVB 
radiation was used and that the presence of the photosensitizer benzophenone accelerated 
the decomposition of quercetin but did not change the three products formed.  In addition, 
the experiment was carried out under reduced oxygen conditions to determine what role 
if any oxidative reactions via ROS played in the decomposition process.  Under reduced 
oxygen the same three products were formed though in a different ratio then under 
atmosphere.   
     The three photoproducts of quercetin were identified to be 2,4,6-
trihydroxybenzaldehyde, 2-(3',4'-dihyroxybenzoyloxy)- 4,6-dihydroxybenzoic acid 
(quercetin depside) and 3,4-dihydroxyphenylethanol (hydroxytyrosol). These three 
products remained consistent when either UVA or UVB radiation was used and when 
quercetin was dissolved in methanol or a methanol-water mix.  Although the three 
products remained the same regardless of the presence or absence of sensitizer or levels 
of oxygen available, the ratios of the three products changed.  In the case of UVR 
exposure in the presence of oxygen without a sensitizer, photoproduct 2 – quercetin 
depside, an oxidation product of quercetin – was favoured.  However, in the presence of 
the triplet state sensitizer benzophenone or under reduced oxygen conditions the extent of 
formation of product 3 was equal or greater than the formation of product 2.  This led us 
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to hypothesize that two separate product formation pathways are present.  In the presence 
of oxygen a type 1 photoreaction is favoured where ROS, likely singlet oxygen, is formed 
and reacts with quercetin to form the oxidation product quercetin depside.  At the same 
time direct absorption of radiation by quercetin results in decomposition of quercetin 
resulting in products 1 and 3, each of which is one half of the parent molecule.  The 
photosensitizer benzophenone mimics the direct absorption reaction in that the excitation 
energy is passed directly to the quercetin molecule resulting in cleavage of quercetin. 
     A literature search of these three decomposition products showed that there was 
minimal toxicity associated with any of them and that formation of them on the skin was 
unlikely to cause any detrimental health effects.  The favourable stability of quercetin 
exposed to light along with the non-toxic nature of what decomposition products are 
formed indicates that quercetin is a good candidate for a topically applied sunscreen. 
     One interesting aspect of the photoproducts of quercetin is found in their UVR 
absorbance spectra.  Quercetin itself has two maximal absorbance bands in the UVA and 
UVC ranges with a minimum in the UVB range.  This results in quercetin offering less 
protection by direct absorption in the high energy UVB while maximum protection 
occurs in  the less energetic UVA range (note that very high energy / highly damaging 
UVC is filtered by the ozone layer in the atmosphere).  However, the 
photodecomposition products of quercetin all have absorbance maxima in the UVB range 
due to the loss of conjugation across the whole molecule.  This led us to speculate that in 
plants where quercetin has been shown to be photoprotective, it may be that quercetin 
alone is only somewhat protective (against UVA) and that the plants rely on the 
formation of the photodecomposition products to provide protection from the UVB.  This 
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hypothesis is outside the scope of the current project as well as the expertise of the 
researchers currently involved with the project, but we believe it is an interesting 
possibility.  In addition, this speculation provides ideas for other compounds to be tested 
as sunscreens in the future. 
8.3 - Determination of quercetin’s ability to prevent photosensitization due to the 
decomposition of the xenobiotic ketoprofen. 
     During the course of the project, it came to our attention that quercetin had been 
shown to prevent breakdown of the topical NSAID ketoprofen (UVR-induced ketoprofen 
decomposition is known to lead to photosensitization), although the mechanism by which 
this protection occurs was not elucidated.  Due to the structural similarities between 
ketoprofen and the photosensitizer we had been using, benzophenone, we speculated that 
quercetin may be preventing ketoprofen photosensitization through transfer of the 
excitation energy from ketoprofen to quercetin, resulting in the formation of the quercetin 
photodecomposition products we had identified.  This was found to be the case, as we 
found that ketoprofen was spared from photodecomposition as a long as quercetin was 
present.  However, this sparing of ketoprofen resulted in the loss of quercetin through the 
formation of the photoproducts we had earlier identified, and once the quercetin was 
consumed ketoprofen degraded as observed by other researchers, possibly leading to 
photosensitization. 
     The possibility that quercetin could have a protective effect not only against direct 
effects of UVR on the skin but also through the prevention of xenobiotic induced 
photosensitization raises the possibility of using quercetin in conjunction with 
pharmaceuticals known to induce photosensitization, hopefully preventing these adverse 
reactions.  However, before any more conclusions can be made in this area the ability of 
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quercetin to prevent the decomposition of other products needs to be tested, a set of 
experiments which falls outside the scope of this project. 
8.4 – Determination of the effect of quercetin on biomarkers of photoaging and 
photoinduced DNA damage. 
     Two of the major negative effects of UVR on human skin are the induction of 
photoaging and damage to DNA, which has the potential to lead to skin cancers.  In order 
to assess the effect of quercetin on these endpoints we chose two biomarkers, MMP-1 for 
photoaging and TNF-α for DNA damage, and assessed the effects of quercetin in HaCaT 
cell cultures and EpiDerm artificial skin mimics.  It was found that quercetin applied to 
either system at concentrations as low as 100µM resulted in a decrease in secretion of 
MMP-1, indicating that quercetin should be an effective protectant against UVR induced 
photoaging.  The effects of quercetin on TNF-α were mixed, with no effect being seen in 
the HaCaT cell, but a significant reduction in TNF-α in the EpiDerm samples indicating a 
decrease in DNA damage, specifically thymine dimer formation.  The differences in the 
TNF-α response between the two sample types may be explained by the difference in the 
routes of administration since in the HaCaT cells the quercetin was administered 24 hours 
before UVR exposure in the media while for the EpiDerm the quercetin was applied 
topically immediately before exposure.  Quercetin has been shown to be unstable in cell 
media which may mean that very little was left to offer protective effects at the time of 
UVR exposure of the HaCaT cells resulting in no protection for DNA damage while the 
topically applied quercetin was present to prevent DNA damage in the EpiDerm samples.  
The goal of this project was to assess the use of quercetin as a topical photoprotectant, 
which means that EpiDerm experiments are more relevant to the mode of application we 
are proposing.  Since quercetin showed significant protective effects against both 
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photoaging and DNA damage in the EpiDerm models, we have concluded that topically 
applied quercetin is an effective photoprotectant against these negative effects of UVR. 
     Use of topically applied quercetin in the EpiDerm samples also addressed another 
possible problem with the use of quercetin as a sunscreen.  Quercetin has a distinct bright 
yellow colour and the concern existed that topical application of some formulation 
containing quercetin at an effective concentration would impart an undesirable yellow 
colour to the skin.  However, the EpiDerm experiments showed that use of quercetin at 
concentrations that provided protection against UVR-induced biomarkers resulted in no 
noticeable yellow colouration being imparted to the skin mimics meaning no negative 
cosmetic effect is present. 
     It is interesting to note that while the HaCaT experiments were initially preformed to 
establish the effectiveness of the end-points chosen and determine a general range of 
concentrations to be tested in the EpiDerm samples, the differences in the mode of 
application of quercetin may provide some insight into quercetin’s mechanism of action.  
There are three main mechanisms by which quercetin may act as a photoprotectant, direct 
absorption of UVR, scavenging of reactive species such as ROS, alteration of metabolic 
pathways or a combination of the three.  Since the HaCaT cells were dosed 24 hours prior 
to UVR exposure with quercetin in the media and the media was removed prior to UVR 
exposure, only  quercetin or its decomposition products which had been absorbed into the 
cell could exert an effect.  As a result the most likely mechanisms of action seen in these 
samples are through antioxidant effects or metabolic pathway effects since the amount of 
light absorbed by quercetin within the cell would be minimal.  In contrast, the quercetin 
applied topically to the EpiDerm samples immediately prior to UVR exposure would be 
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most likely to act through direct absorption of UVR or cell surface antioxidant activity 
since the short exposure time would make absorption and interaction with cellular 
pathways unlikely. 
     Since a significant decrease in MMP-1 secretion is seen in both HaCaT cells and 
EpiDerm skin mimics, it may suggest that the mechanism of action active in the 
prevention of MMP-1 secretion is that mechanism that is shared by both sample types, 
namely antioxidant activity.  Since production of MMP-1 is known to be the result of a 
cascade initiated by oxidation of cell surface proteins, this result makes sense, although 
the possibility that effects on cell signaling may also have an effect cannot be ignored.  In 
contrast to MMP-1, a significant decrease in TNF-α secretion was seen only in the 
EpiDerm samples, not the HaCaT cells.  This result suggests that the mechanism of 
action here is that which is present in the EpiDerm samples but lacking in the HaCaT 
cells, namely direct absorption of UVR.  Again this makes some sense as TNF-α 
production is known to be the result of thymine dimer formation which is a direct UVR 
induced form of DNA damage not acting through ROS.  As such, thymine dimer 
formation, and therefore TNF-α secretion, should not be affected by antioxidant activity 
only by an actual decrease in the amount of UVR reaching the cell.  However, these 
conclusions are speculative at best and full elucidation of the mechanisms involved 
would require a number of experiments beyond the scope of this project. 
8.5 - Conclusions 
     The primary goal of this research project was to assess the effectiveness of topically 
applied quercetin as a possible sunscreen.  We have shown that quercetin has a number of 
characteristics that make it a good candidate for topical sunscreen use.  First, quercetin 
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shows good stability to both UVA and UVB radiation with less than 20% loss of parent 
over a period exceeding normal sun exposure.  In addition the products formed by 
decomposition of quercetin are not known to be toxic.  Second, quercetin has been shown 
to be an effective antioxidant scavenging four radical species for each molecule of 
quercetin when oxidation is initiated by UVB.  Although this number drops to two 
radicals in the case of UVA, this still makes quercetin an effective antioxidant.  Third, 
quercetin has been shown to prevent the decomposition of ketoprofen which can lead to 
photosensitization through the deactivation of ketoprofen, resulting in the formation of 
the previously identified non-toxic decomposition products raising the possibility that 
quercetin could be used in a formulation for topically applied pharmaceuticals that are 
either phototoxic or show photodegradation.  Fourth, when quercetin was applied 
topically to skin mimics there was a significant decrease in the secretion of MMP-1 and 
TNF-α, markers of photoaging and photoinduced DNA damage respectively, two of the 
major deleterious effects of sunlight on skin.  In total, these finding provide evidence that 
topically applied quercetin is an effective form of photoprotection. 
     In addition to the primary goal of assessing the photoprotective potential of quercetin, 
this project also had a secondary goal of developing a series of analytical techniques with 
which other possible photoprotectants could be evaluated.  The techniques that have been 
used in this project have now been well established and are available for assessment of 
other compounds. 
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9.  Future Work  
     Although the primary and secondary research goals of this project have largely been 
achieved, and number of additional questions remain to be answered.  
9.1  Formulation 
     Quercetin has been shown to be an effective photoprotectant, but the method of 
application used in this study, application of quercetin dissolved in acetone, is not 
suitable for commercial use due to the drying effects of acetone.  If use of quercetin as a 
sunscreen or a component of a sunscreen formulation is to be achieved a useable matrix 
for application such as an inert cream would need to be found and evaluated. 
9.2  Non-surrogate DNA endpoint 
     In the EpiDerm and HaCaT experiments, MMP-1 and TNF-α were used as biomarkers 
for photoaging and DNA damage respectively.  MMP-1 secretion is an effective end-
point, but TNF-α could be replaced with a more direct endpoint.  An HPLC-MS-MS 
method for the determination of thymine dimers in cells was partially developed but 
validation for analysis in cell extracts was not achieved.  Complete development and 
validation of this method would be an asset in evaluation of future sunscreen candidates. 
9.3  Prevention of photosensitization by other xenobiotics 
     Quercetin was shown to prevent the photodecomposition of ketoprofen, a reaction 
causing photosensitization, through absorption of excitation energy.  Assessment of the 
ability of quercetin to prevent photosensitization by other drugs or environmental 
contaminants could demonstrate even greater utility for quercetin as a sunscreen.  The 
prevention of photosensitization would have to be measured in terms of quercetin’s 
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ability to both prevent photodecomposition or excitation of the sensitizer and in terms of 
prevention of negative biological end-points. 
9.4  Mechanism of action  
     Although some possible mechanisms of action for the photoprotective action of 
quercetin have been suggested here, these are on suppositions.  Clear elucidation of the 
mechanisms involved would require a large number of experiments in which the other 
mechanisms were blocked in order to confirm the suspected mechanism is the active one.  
However, such experiments would provide valuable information on the effects of 
quercetin and related compounds on the skin and on the body in general. 
 
